Lipolytic activities in postheparin serum by Jansen, H. (Hans)
LIPOLYTIC ACTIVITIES 
IN POSTHEPARIN SERUM 
PROEFSCHRIFT 
TER VERKRIJGING VAN DE GRAAD VAN DOCTOR IN DE GENEESKUNDE 
AAN DE ERASMUS UNIVERSITEIT TE ROTTERDAM 
OP GEZAG VAN DE RECTOR MAGNIFICUS PROF. DR. P.W. KLEIN 
EN VOLGENS BESLUIT VAN HET COLLEGE VAN DEKANEN. 
DE OPENBARE VERDEDIGING ZAL PLAA TS VINDEN OP 
WOENSDAG 2 JUL! I975 DES NAMIDDAGS TE 4.15 UUR PRECIES 
DOOR 
HANS JANSEN 
GEBOREN TE DEVENTER 
I975 
BRONDER OFFSET B.V.- ROTTERDAM 
PROMOTOR 
CO-REFERENTEN 
PROF. DR. W.C. HULSMANN 
PROF. DR. J.C. BIRKENHAGER 
DR. J. FERNANDES 
Het onderzoek werd uitgevoerd onder auspicien van de Stichting Scheikundig Onderzoek in Neder-
land (S.O.N.) en ten dele gefinancierd door de Nederlandse Organisatie voor Zuiver Wetenschappe-
lijk Onderzoek (Z.W.O.) 
Ter nagedachtenis aan mijn vader 
Aan mijn moeder 
Aan Loes 
Contents 
VOORWOORD 
INTRODUCTION 
CHAPTER I 
CHAPTER II 
REFERENCES 
SUMMARY 
SM!ENVATTING 
Lipase activities in postheparin 
serum 
The role of the liver in serum 
triglyceride removal 
CURRICULUH VITAE 
APPENDIX PAPERS 
I Long-chain acyl-CoA hydrolase activity in serum: 
identity with clearing factor lipase. 
8 
10 
ll 
16 
27 
32 
34 
37 
H. Jansen and W.C. Hiilsrnann (1973) Biochim. Biophys. 
Acta 296, 241-248. 
II Lipoprotein lipase from heart and liver: an immuno-
logical study. 
H. Jansen, A. van Zuylen-van \'liggen and N.C. Hiils-
mann (1973) Biochem. Biophys. Res. Commun. 55, 30-37. 
III Liver and extrahepatic contributions to postheparin 
serum lipase activity of the rat. 
H. Jansen and N.C. Hlilsmann (1974) Biochirn. niophys. 
Acta 369, 387-396. 
IV On the selective measurement of hepatic and extra-
hepatic postheparin serum lipase activities and the 
influence of experimental hypercortisolisrn and 
diabetes on these activities. 
H. Jansen and t'l.C. Hiilsmann (1975) Biochim. Biophys. 
Acta, accepted for publication. 
V Increase in postheparin lipoprotein lipase activity 
in rat plasma by dietary erucic acid. 
C.B. Struijk, U.H.T. Houtsrnuller, H. Jansen and 
w.c. Hlilsrnann (1973) Biochirn. Biophys. Acta 296, 
253-256. 
VI Influence of rapeseed oil feeding on the lipase 
activities of rat heart. 
H. Jansen, A. van Zuylen-van t'liggen, N.C. Hlilsrnann, 
C.B. Struijk and U.H.T. Boutsmuller (1975) Biochern. 
Biophys. Res. Commun., accepted for publication. 
. VOORWOORD 
Bij het voltooien van di t proefschrift v1il ik allen, 
die op een of andere wijze het schrijven ervan rnogelijk 
gemaakt hebben, danken voor hun bijdragen. 
In de eerste plaats dank ik mijn moeder, dat ik in de 
gelegenheid gesteld ben om te gaan studeren. Aan allen, 
die tijdens mijn studie in Amsterdam onderricht in de 
scheikunde hebben gegeven, ben ik veel dank verschuldigd. 
Willem Hiilsmann, jouw goede ideeen hebben dit onder-
zoek begeleid. Uit jouw, al lang bestaande, interesse in 
lipoproteine lipase is dit proefschrift voortgekomen, ik 
ben je erkentelijk veer de wijze waarop je jouw enthou-
siasme voor de fysiologisch gerichte biochernie op rnij hebt 
overgebracht. 
De beide coreferenten, professor dr. J.C. Birkenhager 
en dr. J. Fernandes, dank ik voor het bekritiseren van dit 
proefschrift en voor de stimulerende interesse voor het 
onderzoek, die ik de afgelopen jaren bij hen heb ontmoet. 
Dankzij de medev1erking van dr. U.H.T. Houtsmuller en 
mej. drs. C.B. Struijk van Unilever Research, Vlaardingen, 
konden de experirnenten met raapzaadolie dieten uitgevoerd 
worden. 
Van vele rnedewerkenden aan andere afdelingen van de 
Erasmus Universiteit heb ik hulp en advies gekregen. In 
het bijzonder ben ik Paul Bakhuys van Chemische Pathologie 
voor het onderricht in immunisatietechniek en Wil Kort van 
Experimentele Chirurgie voor het hepatectomeren van ratten 
veel dank verschuldigd. 
Cecile Hanson, ik dank je voor de buitengewoon snelle 
en accurate manier waarop je dit proefschrift hebt getypt, 
ondanks je vele andere bezigheden. Mieke d 1 Hamecourt dank 
ik voor het typen van een aantal van de artikelen. 
Anita van Zuylen-van Wiggen, jou komt veel lof toe 
voor de wijze waarop je de experimenten hebt uitgevoerd. 
Je goede humeur in goede en slechte tijden, bij geslaagde 
8 
en niet geslaagde experimenten, zijn zeer belangrijk voor 
het verloop van het onderzoek geweest. 
Alle andere medewerkers van de afdeling Biochernie I 
dank ik voor de plezierige werksfeer en hun direkte of in-
direkte hulp tijdens het onderzoek. 
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een grote steun voor mij geweest, ik ben je hiervoor dank-
baar. 
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INTRODUCTION 
Dietary fat is, after hydrolysis and reesterification 
in the intestine, transported by the blood mainly in the 
form of triglycerides. To enable the transport of the hydro-
phobic lipid in the aqueous bloodplasrna, a protein envelope 
is synthesized around the triglycerides in the intestine. 
The particles formed in this way are called chylomicrons. 
Endogenous triglycerides synthesized in the liver from free 
fatty acids and carbohydrates are secreted by the liver in an 
analogous manner. These liver particles are smaller than the 
chylomicrons and have a relatively high protein content. They 
are called very low density lipoproteins (VLDL) . In the break-
down of the triglyceride moiety of both chylomicrons and VLDL 
an enzyme located at the surface of endothelial cells of 
bloodvessels, is involved. This enzyme, lipoprotein lipase, 
is released into the blood after injection of heparin. The 
measurement of the lipoprotein lipase activity in postheparin 
serum is an important tool in the study of serum triglyceride 
metabolism. 
We found that serum of rats injected v;i th heparin (post-
heparin serum) also hydrolyzes palrnitoyl-CoA and the develop-
ment of a simple continuous assay of the serum lipase activity 
seemed to be at hand. In subsequent experiments, it became 
clear that a mixture of different enzymes is released by hepa-
rin into the blood. Therefore v1e attempted to measure these 
lipase activities selectively. Nhen this was achieved, the 
influence of some factors on the different lipases , .. ,as studied. 
Chapter I gives a brief literature survey of the lipase 
activities of postheparin sera of different species. In this 
chapter the most important facts known about the function of 
these different lipolytic activities are described. 
In chapter II the role of the liver in serum triglyceride 
metabolism is discussed by an integration of literature data 
with our own experiments. Some additional experiments are 
shown. 
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CHAPTER I 
LIPOLYTIC ACTIVITIES IN POSTHEPARIN SERUH 
1.1. Lipoprotein lipase in different organs and in posthe-
parin serum 
In 1943 it was demonstrated by Hahn1 that serum of 
hyperlipemic dogs could be cleared by heparin injection. 
This activity was called "Clearing Factor". Later it was 
shown that in a number of other species, including man, 
this "Clearing Factor" became active upon in vivo admini-
stration of heparin2 ' 3 
In 1955 Korn4 found that acetone-powders of rat hearts 
contain a lipase activity, that is activated by serum pro-
teins and heparin. This lipase activity was called lipo-
protein lipase. It ;,1as postulated that the "Clearing Fac-
tor" discovered by Hahn \-las identically v1i th the lipopro-
tein lipase, released from the organs by the interaction 
vli th heparin. Also in lung, adipose tissue, diaphragma, 
lactating mammary gland and other organs a lipase activity 
with the characteristics of lipoprotein lipase is described 
(camp. ref. 5). The characteristics of lipoprotein lipase, 
as defined by Korn4 , are: it is inhibited by preincubation_ 
with high salt concentrations or protamine sulphate and sti-
mulated by heparin and serum proteins. The function of the 
enzyme was considered to be the hydrolysis of serum trigly-
cerides at the endothelial cells of the organs, in 
order to facilitate the uptake of these triglycerides by 
the organs. The easy release of the lipase activity from 
the organs by heparin injection led to the conclusion that 
at least part of the lipase activity is located at the endo-
6-8 thelial cells facing the luminal space • It was later 
shown that at least two forms of lipoprotein lipase activi-
ty, differing in molecular weights, exist in defatted pre-
parations of rat heart and adipose tissue9- 11 . The high 
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molecular form was considered to be releasable by heparin 
and to function in the hydrolysis of serum triglycerides. 
It was also postulated that the lipoprotein lipase 
activity may be altered under different feeding conditions. 
Fasting was shown to result in an elevation of the lipo-
protein lipase activity in {rat) heart 12 , while that acti-
vity in adipose tissue was found to be lowered6 ' 7 ' 13 , 14 and 
the lipase activity of lung unaffected15 . The lipoprotein 
lipase activity in rat heart is perhaps regulated by gluca-
16 17 gon , although conflicting reports exist The lipopro-
tein lipase activity of another triglyceride utilizing 
organ, lactating mammary gland, was found to be regulated 
by prolactin18 . The level of the lipoprotein lipase of an 
organ seems to correlate with the demand of serum trigly-
cerides by the organ1S,l?,l 9- 21 . Especially the activity of 
the heparin-releasable part of the lipase activity deter-
mines the uptake capacity of the organs of serum triglyce-
rides, as was found for rat heart 19 and rat adipose tissue 11 . 
The estimation of the lipoprotein lipase activity of 
different organs is important for the understanding of serum 
triglyceride metabolism. The measurement of activity in an 
organ requires large biopsies, which is often impossible 
(especially in humans). Besides, the activity in the organs 
is composed of heparin-releasable and non-releasable acti-
vities (see e.g. appendix paper VI and refs. 9-11) and are 
therefore not necessarily related to the serum triglyceride-
uptake capacities of the organs. Therefore, the heparin-
releasable part of the total lipoprotein lipase activities 
of the organs should be measured selectively. This may be 
done in the serum after the intravenous injections of hepa-
rin. However, the lipase activity of postheparin serum is 
rather inhomogenous, as different organs might contribute 
(comp. Discussion in the next sections of this chapter). 
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1.2. Hepatic lipase activity in postheparin serum 
The lipase activity of postheparin serum was considered 
to be identical with lipoprotein lipase, derived from extra-
hepatic organs, for a long time, although reports existed 
that heparin releases lipase activity from rat liver22 , dog 
liver 23 r 24 and human liver25 . La Rosa et a1. 26 found in 
1972 that the lipase activity of postheparin rat serum re-
sembled a lipase activity in a liver preparation more than 
the lipoprotein lipase activity of adipose tissue, with 
respect to inhibition by preincubation with high salt con-
centrations and protaminesulphate.Since then more attention 
has been paid to the contribution of the liver to the total 
lipolytic activity of postheparin serum of different 
species 27 - 30 . Most investigators made use of the reported 
resistence of the liver enzyme to inactivation by protamine-
sulphate and/or high salt concentrations. However, these 
criteria have been criticized32 , while it was found that 
the results obtained were largely dependent on the substrate 
32 33 
used ' • Moreover, the enzyme purified from rat liver was 
found to be equally sensitive to the inhibitors mentioned, 
as the extrahepatic lipoprotein lipase34 
We were the first to describe (appendix papers II and 
III) that the liver enzyme is immunologically different from 
the extrahepatic lipoprotein lipase in the rat. In prelimi-
nary experiments the same was found in man. Therefore a 
differentiation between hepatic and extrahepatic lipases in 
postheparin serum became available (appendix paper III) • 
Differentiation of both activities is also possible by the 
use of substrates, that are preferentially hydrolyzed by one 
of the enzymes (appendix papers I and IV). We were able to 
show that the contribution of the liver to the total lipase 
activity of the serum is dependent on the amount of heparin 
injected and the time of blood removal after the injection 
in rat or man (appendix papers III and IV and ref. 30). It 
was further shown that in the rat the hepatic lipase acti-
13 
vity was lowered during fasting, experimental diabetes and 
experimental hypercortisolism (appendix paper IV) • Diets 
containing large amounts of fat (in addition to carbohydra-
te) or large amounts of carbohydrate cause an increase of 
the hepatic lipase activity (appendix paper III and chap-
ter II). These dietary adaptations of liver activity are 
possibly related to or exerted by variations in the gluca-
gon/insulin levels of the blood as will be described in 
chapter II. 
1.3. Other lipolytic activities in postheparin serum 
In the previous sections the contributions of different 
organs to the triglyceride hydrolyzing activity of post-
heparin serum was discussed. Apart from these activities 
other lipolytic activities are present in postheparin serum. 
Vogel and Bierman35 found that a phospholipase activity is 
released into the serum after heparin injection. This 
activity can be purified from rat liver parenchymal cells 36 . 
1-Monoglyceride and 2-monoglyceride hydrolyzing activities 
are both found in postheparin serum37 - 44 and in heparin-
containing rat liver perfusates45 . The 1-monoacylglycerol-
hydrolase activity may be identical with the heparin-releas-
able phospholipase activity46 . The 2-monoacylglycerol lipase 
activity is perhaps exerted by the same enzyme as the tri-
glyceride lipase activity from the liver (appendix paper 
IV). 
The different lipolytic activities of postheparin serum 
may influence each other when measured in vitro. The phos-
pholipase may transfer acylgroups from different substrates 
to compounds, produced by other enzymes in the serum. The 
liver lipase activity may be operative in the breakdown of 
partial glycerides produced by the action of extrahepatic 
lipoprotein lipase upon triglycerides (see e.g. appendix 
paper IV) . These facts may help to explain the variable 
results, that are obtained when using different substrates, 
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as was mentioned before. 
1.4. Concluding remarks 
Heparin releases different lipolytic activities from 
different organs into the serum. The lipoprotein lipase 
activities of extrahepatic organs correlate well with the 
capacity of these organs to take up serum triglycerides.The 
role of the liverlipase is much less clear (see chapter II). 
The selective measurement of different lipolytic activities 
in postheparin serum will contribute to a better understan-
ding of the serum lipid metabolism in health and disease. 
As described in section 1.2. of this chapter, the lipase 
activities of hepatic and extrahepatic origin can now be 
measured separately. A further differentiation should be 
made between the enzyme activities released from extrahepa-
tic sources, such as adipose tissue and (heart-) muscle. 
If this could be achieved a further understanding of 
serum lipid metabolism and the role of different organs in 
this process may be expected. 
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CHAPTER II 
THE ROLE OF THE LIVER IN THE SERUM TRIGLYCERIDE REMOVAL 
There is general agreement that the liver is the main 
site of endogenous serum triglyceride production47 - 50 • The 
removal of serum triglycerides, however, is a controversial 
subject51 - 55 . In the serum of hepatectomized dogs remnant 
particles are found 56 • These remnant particles or "remnants" 
may be produced as intermediates in the breakdown of chyle-
microns and very low density lipoproteins (VLDL) to low 
density lipoproteins (LDL). LDL particles with an increased 
triglyceride content may be considered as remnants, but 
61 
also VLDL with an increased cholesterol content are found . 
The production of such remnants has been demonstrated in 
different species56- 59 • These particles may, in addition to 
triglycerides, contain partial glycerides, as can be expected 
from incomplete breakdown of triglycerides by the extrahepa-
tic lipoprotein lipase(s) (comp. appendix paper IV). Recently 
a number of papers has appeared in which an enhanced level 
of remnant particles in man was demonstrated in patients with 
liver disease60 , hypothyreoidism61 and diabetes 62 . The in-
creased level of remnants seems to correlate with a lowered 
hepatic heparin-releasable lipase activity30 , 60 , 61 This 
suggests a role of the liver lipase in the removal of rem-
nant (tri)glycerides from the serum. Whether also intact VLDL 
or chylomicrons are taken up by the liver is not clear. Up-
take of injected VLDL by rat liver has been demonstrated by 
stein et a1. 55 . 
The possibility to measure the lipases of hepatic and 
extrahepatic origin in postheparin serum selectively (see 
chapter I) has become available, which allows us to correlate 
liver lipase activities with the levels of blood lipids found. 
Moreover, data in the recent literature also suggest a role 
of the liver lipase in serum triglyceride metabolism. Some of 
these arguments in favour of a role of liver lipase in the 
16 
cataholisro of blood (tri)glycerides can be found in the 
discussion of appendix paper IV o i'\dditional support will be 
given nm·l. 
Stein et a1. 55 found VLDL accumulation at the plasma 
membranes of rat parenchymal liver cells, prior to the up-
take of these particles in the cells. The liver lipase is 
located on the outersurface of the plasma membranes of liver 
34 63 9arenchymal cells ' . Parenchymal cells are much less in-
volved in pinocytosis than Kupffer cells. Therefore hydro-
lysis of the trirylyceride moiety of the VLDL particles, which 
then decrease in size, might preceed uptake of the particles 
in the parenchymal cells. 
The effect of the nutritional state on liver lipase 
activity (appendix paper III) is in line with the hypothesis 
of a role for this enzyme in serum triglyceride breakdown. 
Under fasting conditions the liver is the site at which the 
major part of the serum triglycerides is produced. Therefore 
the lowered hepatic and adipose tissue lipase activities 
under this condition may result in a channeling of the tri-
glycerides formed to the site where they should be used: 
the musculature, including heart muscle. In this context 
it may be of interest to note that both the liver lipase 
activity and the fat clearance by the heart of rapeseed oil 
fed rats are elevated (appendix papers III, V) o During 
rapeseed oil feeding of rats, the heart rapidly accumulates 
triglycerides (for references camp. appendix papers V, VI) 
to reach a maximum in about 6 days, after which the lipid 
content decreases, although rapeseed oil feeding is con-
tinued. The elevated liver lipase might have resulted in 
a channeling of more triglycerides to the liver, which is 
in accordance with the observation of Gumpen and Norum64 
that the liver erucylcarnitine level is increased when the 
triglyceride content of the fatty heart diminishes. There-
fore the elevation of liver lipase activity under feeding 
conditions may provide a mechanism to avoid high levels of 
remnants to accumulate in the blood. Such an accumulation 
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·TABLE I 
ALTERATION OF HEPARIN-RELEASABLE LIVER LIPASE ACTIVITY 
UNDER THE INFLUENCE OF DIFFERENT FEEDING CONDITIONS AND 
INSULIN ADMINISTRATION 
Rats v1ith an average weight of 280 g were used. Glucose 
(3 ml 10% glucose in destilled water) was administered 15 
min before the subcutanous injection of insulin by a 
stomach tube. 50 I.U. of heparin were injected intravenous-
ly 1 h after the administration of insulin or 1 h after the 
start of the infusion of rnannoheptulose. 6 min after the 
heparin injection blood was vlithdrawn. The lipase activity 
in the postheparin serum was measured '\·lith palmitoyl-CoA as 
the substrate, as described in appendix paper I. As was 
shovm elsev1here (appendix paper IV) this activity mainly 
reflects the liver lipase activity. Insulin v1as from Organon 
{Oss, the Netherlands), mannoheptulose was a gift from the 
Pfizer Company. 
Dietary 
conditions 
normally fed 
normally fed 
normally fed 
24 h fasted 
24 h fasted 
24 h fasted 
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(n=6) 
(n=4) 
(n=3) 
(n=3) 
(n=2) 
(n=3) 
Treatment 
none 
0 0 3 g rnannoheptulose 
infused i. v. in 1 h 
Oo5 I.U o insulin s.c. 
none 
Oo5 I. u 0 insulin s.c. 
glucose + Oo5 I.Uo 
insulin s .c. 
Palrnitoyl-CoA 
hydrolase 
activity 
{nmoles CoASH/ 
min/ml) + S.E. 
220 + 8 
194 + 13 
251 + 12 
166 + 7 
184 (161,207) 
245 + 5 
would be an undesirable situation, as has been pointed out 
by Bierman et a1. 65 . The penetration of these particles 
under the endothelial lining of bloodvessels, possibly the 
start of atherosclerotic plaque formation65 should be 
avoided. Therefore the elevation of the liver enzyme acti-
vity during fat feeding (appendix paper III) will be 
advantageous. During fat feeding more chylomicrons will be 
produced in the intestinal cells and subsequently more 
remnants by the interaction with extrahepatic lipoprotein 
lipase. The elevated liver lipase activity may then be an 
adaptation to the increased synthesis of these remnant 
particles. In TABLE I it is shown that the liver lipase 
activity is decreased by tasting or mannoheptulose admini-
stration. Under these circumstances the glucagon/insulin 
ratio will be elevated. One hour after the administra-
tion of insulin cum glucose to fasted rats the liver lipase 
activity reaches a value slightly above the value found in 
the normal fed state. Insulin alone gives a much lower 
response. It is of interest to note that the liver enzyme 
may be regulated in the same way as adipose tissue lipo-
protein lipase8 ' 14 , 66 . The fast elevation of the lipase 
activity by insulin treatment suggests that protein syn-
thesis is not involved in the activation of the enzyme, 
but that the activation is exerted by some other mechanism. 
In appendix paper III we have shov.m that the liver lipase 
may exist in different states of activity. In preliminary 
experiments we found that the aggregation state of enzyme 
subunits may be involved in the degree of activation of 
the enzyme. In these experiments v1e found that the puri-
fied rat liver enzyme (appendix paper II) contained four 
protein bands in polyacrylamide electrophoresis. Antisera 
raised against each of these proteins inhibited the liver 
lipase activity completely. Also the liver lipase activity 
of human postheparin serum may depend on the state of 
aggregation of subunits, as v1as suggested by the experi-
ments of Ehnholm ~.31 . 
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The contradictory results on the ability of the liver 
to take up serum triglycerides (comp. refs. 52 and 53) can, 
at least in part, be explained by the feeding conditions 
of the animals used. Felts and Hayes 53 found no uptake of 
chylomicron triglyceride by the liver of fasted rats, while 
in carbohydrate-fed rats 30-40% of injected chylomicron 
triglyceride may be taken up 52 As was discussed above and 
was shovm in appendix paper III, the liver lipase activity 
is in different states of activation during feeding and 
fasting. Another explanation of the difference of results 
of Felts and Hayes 53 and of Olivecrona et a1. 52 may be 
-- 53 found in the different systems used. Felts and ~-1ayes 
studied the uptake of chylomicrons by in vitro perfused 
rat liver. Chylomicrons vlith a diameter above 0.1 ~ cannot 
pass the fenestrated endothelial lining of the liver67 . 
However, the much smaller VLDL and remnants can enter the 
space of Disse much more easily. In the intact rats used 
by Olivecrona et a1. 52 the uptake of chylornicrons might 
have been preceded by partial breakdown to smaller par-
ticles by extrahepatic lipoprotein lipase. In this regard 
it is explicable also why whole rat liver cannot take up 
chylomicrons, although isolated cells, without a size-
limiting vascular barrier, can hydrolyze chylomicron tri-
glycerides54,68. 
To what extent the liver hydrolyzes and takes up VLDL 
triglycerides is not clear yet. In TABLE II it is shown 
that antiserum raised against the liver lipase inhibits 
the lipase activity of postheparin serum to a greater 
extent when higher substrate concentrations are used. This 
means that in vitro more triglyceride is hydrolyzed by the 
liver enzyme than by the extrahepatic lipase(s), when the 
substrate concentration is high. At low concentrations tri-
glyceride is predominantly hydrolyzed by the extrahepatic 
lipase activity. From these data it seems likely that the 
the triglyceride substrate liver enzyme has a higher K 
m 
than the lipoprotein lipase. 
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for 
Because of non-hyperbolic 
TABLE II 
DEGREE OF INHIBITION OF POSTHEPARIN SERUM LIPASE ACTIVITY 
BY LIVER LIPASE ANTISERml AT DIFFERENT SUBSTRATE CONCEN-
TRATIONS. 
Serum lipase activity of rats, injected with 50 I.U. hepa-
rin, was estimated after preincubation with antiserum 
against the liver lipase or with control rabbit serum, 
exactly as described in appendix paper III. The substrate 
concentration was varied. The percentage inhibition of the 
total lipase activity by antiserum is presented. 
Triglyceride concentration 
in mH 
10 
5 
2.5 
1. 25 
0.63 
Percentage inhibition 
by the antiserum 
52 
46 
42 
36 
33 
kinetics the Km values were not calculated. The results 
obtained in vitro suggest that also in vivo the liver 
lipase is relatively more active at higher serum triglyce-
ride concentrations. If this enzyme activity is rate-
limiting in the uptake of triglycerides by the liver, then 
the liver plays a more important role in the removal of 
serum triglycerides when the serum concentration is high. 
In this way the liver can perhpas exert a kind of overflow 
function, in order to prevent excessive elevation of serum 
triglyceride levels, at least when the triglycerides can 
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pass the endothelial fenestrae, as discussed above. Vlhen 
high doses of triglycerides are administered to humans 
intravenously, a fast removal of triglycerides from the 
blood precedes a slower hyperbolic phase of clearing69 . It 
is possible that in the fast clearing phase the liver is 
involved, while in the slower phase the extrahepatic 
organs play a predominant role. 
In order to test this hypothesis, fat clearing experi-
ments were carried out in rats. It can be seen from TABLE 
III that the bulk of the radioactive label v;as recovered in 
the liver while in the hepatectomized rats practically all 
of the radioactivity (present in the triglyceride fraction; 
details not sho\lm) remained in the blood. Therefore in this 
model the liver seems to be the main site of uptake. For 
the human species it \!las reported 70 , however, that arti-
ficial fat emulsions \llere not taken up by the liver. 
Nhether a species difference, or perhaps a difference in 
particle size (a smaller particle size brought about by 
sanification of our emulsions) accounts for the different 
results, is not clear, but requires further investigation. 
From the results \ld th hepatectomized rats and heparin-
treated rats it seems not very likely that the uptake of 
the labeled fatty acid by the liver is preceded by extra-
hepatic hydrolysis of the triglycerides. If this would have 
been the case, the label might have been expected to be 
present in the serum free fatty acid fraction. In the hepa-
rin-treated rats, when part of the triglyceride fraction is 
hydrolyzed in the serum, an enhanced uptak.e of the label in 
the liver would have been expected. Hhether the liver 
lipase activity is involved in the uptake of the fat emul-
sion cannot be concluded from this TABLE. In other experi-
ments we found that 5 min after injection of the fat emul-
sion 50% of the triglycerides taken up by the liver was 
hydrolyzed. 
In conclusion: we suggest that the liver may play an 
important role in the serum triglyceride metabolism, not 
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TABLE III 
DISTRIIlUTION OF A" INTRAVENOUSLY ADl!INISTERED [ 14c] -LABELED 
FAT El1ULSION OVER THE ORGANS OF THE RAT. 
Hale \Vistar rats (about 250 g) v1ere injected with 0.2 ml 
Intralipid. The Intralipid used was fortified with glycerol 
tri[14c]-oleate as described in appendix paper I. 20 min 
after the injection the rats \·lere l::illed, the organs rer.toved 
and rinsed '~:lith 0. 9% NaCl. Samples of about 0 .1 g were dis-
solved in ''Soluene-350'' in 3-4 h at 60°C. After cooling to 
roomtemp., 0.2 ml 30% II 2o2 and 0.2 ml isopropanol were 
added and the mixture v1as incubated for 30 min at 40°C. The 
sample~:; were counted with 5 ml "Dimilurne" and 5 rnl "Instagel". 
The d.p.m. obtained 'i'lere divided by the sample fraction taken 
fran the whole organ. Skeletal muscle samples were obtained 
from the thigh bone and assumed to be representative for the 
entire musculature. Functional hepatectomy was achieved as 
described in appendix paper III. In the experiment with the 
heparin-treated animals 50 I.U. heparin were injected to-
gether with the Intralipid. "Soluene", "Dimilume" and "Insta-
gel" were oLtained from Packard. Intralipid (10%) was from 
Vitrum, Stockholm. 
Organ 
serum 
Liver 
heart 
epidydimal 
adipose tissue 
skeletal muscle 
% of the injected radioactivity recovered 
normal 
rats 
9 
64 
2 
l 
7 
hepateCtomized 
rats 
95-100 
heparin 
treated rats 
4 
50 
l 
7 
8 
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f adipose tissue 
remnants 
c 
Fig. 1. Schematic representation of serum triglyceride metabolism 
only in the production of serum triglyceride, but also in 
the renoval of serum triglycerides. In the latter process 
the liver lipase activity may be a rate-li:r.:titing factor. 
In accordance with this are the data of other investiga-
tors (comp. e.g. refs. 60, 30 and 61). Although under 
normal conditions only 20% of the daily fat uptake reaches 
the rat liver directly it seems to be possible that a 
lowering of the liver lipase activity can lead to hyper-
triglyceridemia. 
The role of the most important organs in serum tri-
glyceride metabolism is summarized in fig. 1. In this 
figure the reactions designated Hith (A) are thought to 
be catalyzed by lipoprotein lipase which hydrolyzes tri-
glycerides to free fatty acids and monoglycerides (comp. 
also the Introduction and chapter I) . In the reactions (B) 
and (C) liver lipase is thought to be involved. 'de would 
suggest that reaction {B) is only of importance at high 
VLDL levels and perhaps under certain dietary conditions 
when the liver lipase activity is elevated. Reaction (C) 
is the major pathway for the brea};:down of the triglyceride 
moiety of remnant particles. This process may take place 
at the surface of the hepatocytes, where the lipase is 
located. The fate of the LDL formed is not certain. They 
may be released into the circulation, taken up by paren-
chymal or non-parenchymal cell types of the liver. It 
seems reasonable to state that in the removal of artificial 
fat emulsions, as shov;n in TABLE III of chapter II, the 
liver lipase activity is also involved. In this context it 
must be emphasized that artificial triglyceride emulsions 
lack proteins to activate extrahepatic lipoprotein lipase 
(the same holds for the remnants). However, these activa-
ting proteins may be taken uP from other serum lipoproteins 
in the circulation. 
For the study of serum triglyceride metabolism in 
health and disease it will be of considerable importance 
to be able to measure the liver lipase activity in post-
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heparin serum. Of special interest is the possible corre-
lation between the remnant particle level and the develop-
ment of atherosclerosis. It was postulated by Zilversmit71 
and by us 72 that an increased heart-lipoprotein lipase 
activity may, under certain conditions, lead to athero-
sclerosis. Now ~;e have found that the liver lipase activi-
ty is low under conditions that the heart lipase activity 
is high (compare TABLE I and refs. 12 and 16). If this 
situation is accompanied by a high serum triglyceride 
level, as in diabetes and under stress conditions, then an 
elevated level of remnant particles if to be expected. This 
may lead to hypercholesterolemia together with hypertrigly-
ceridernia. Hypothyroidism61 , type III 73 (possibly type V 
74 ) hyperlipoproteinemia, diabetes 62 and cholesterol-rich 
diets75 are all accompanied by an elevated remnant particle 
concentration. The atherogeneity of these conditions is 
well established. 
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SUMMARY 
The presence of palmitoyl-CoA hydrolase activity in 
postheparin serum of man and rat has been described. It 
was found that this activity vtas released from different 
organs into the blood after the intravenous injection of 
heparin. In the rat the liver contributes about 80% of 
the total activity in postheparin serum. 
The immunological difference between lipase species 
of rat liver and extrahepatic organs was established. By 
using an antiserum against the liver lipase, a selective 
measurement of different lipases in postheparin rat serum 
has become available. It was shown that the contributions 
of the liver and the extrahepatic organs to the total 
lipase activity of postheparin serum, were strongly depen-
dent on the amount of heparin injected and on the time of 
blood removal after the injection. lVhen low heparin 
amounts are injected, predominantly the extrahepatic 
organs release their lipase activity. Furtheron it was 
shovJn that the liver lipase species was released faster 
than the extrahepatic lipase activity by heparin in man and 
rat and that it disappeared from the blood soon after the 
maximum activity had been reached~ Arguments were brought 
forward that the liver lipase activity was removed from 
the serum by removal of the enzyme, and not by inactivation 
in the blood stream. By immunological means it was shown 
that the liver lipase might exist in more or less activated 
states. The state of activation was found to be influenced 
by the blood insulin level and probably related to the 
glucagon/insulin ratio. A high ratio corresponds with 
lowered hepatic lipase activity, while the administration 
of insulin enhances the liver lipase activity. This is an 
explanation for the decreased hepatic lipase activity 
during fasting and in diabetes. 
The liver and the extrahepatic lipases in postheparin 
serum have a different substrate specificity and possibly 
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a different affinity for a triglyceride substrate, the 
liver enzyme having a relatively low affinity. From in 
vitro experiments an overflow function of the liver in the 
control of the blood triglyceride level was postulated. 
Also a function of the liver in the removal of remnant par-
ticles was discussed. In both instances the heparin-releas-
able lipase activity seems to be a rate-determining factor. 
Our results were related with those of other investigators. 
The effects of experimental hypercortisolism, experi-
mental diabetes and some diets on the liver lipase and 
extrahepatic lipoprotein lipase activities were studied. 
The study of the effects of rapeseed oil feeding on hepa-
tic and heart lipase activities revealed that prolonged 
feeding results in increased activities of the non-heparin 
releasable (and therefore probably the intracellular-) 
myocardial enzyme together with the heparin-releasable 
hepatic enzyme. These adaptations provide an explanation 
for the gradual removal of myocardial triglyceride after a 
period of excessive accumulation early during rapeseed oil 
feeding. 
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Sl\HENVATTING 
De aanwezigheid van palmitoyl-CoA hydrolase aktivi-
teit in het bleed van met heparine ingespoten ratten werd 
vastgesteld. Deze aktiviteit blijkt voor 80% uit de lever 
afkomstig te zijn. Ook in de mens wordt palrnitoyl-CoA hy-
drolase aktiviteit door heparine in de bloedbaan gebracht. 
De lipase welke door heparine ui t de lever ~10rdt 
vrijgemaakt is imrnunologisch verschillend van de lipase 
uit andere organen. Net behulp van een specifiek anti-
serum tegen de rattelever lipase, konden de lipase aktivi-
teiten van hepatische en extrahepatische oorsprong in 
postheparine serum afzonderlijk bepaald worden. Het bleek 
dat de bijdragen van de lever en van de extrahepatische 
organen, tot de totale postheparine serum lipase aktivi-
teit, sterk afhankelijk zijn van de toegediende hoeveel-
heid heparine en de tijd van blocdafname na de injectie. 
Na injectie van een lage heparine dosis wordt vooral 
extrahepatische lipase aktiviteit in het serum gevonden. 
Bij gebruik van hoge heparine doses, echter, wordt de 
lever lipase sneller vrijgemaakt dan de extrahepatische 
lipoproteine lipase. De verdv.;ijning van lever lipase ak-
tiviteit uit het bleed, nadat een rnaximale aktiviteit is 
bereikt, is waarschijnlijk het gevolg van verwijdering van 
het enzyrn uit de bloedbaan en geen gevolg van inaktivatie 
van het enzym in de bloedbaan. 
De door heparine vrij te maken lever lipase kan zich 
in een meer of minder aktieve toestand bevinden. Dit kan 
worden belnvloed door de insuline concentratie van het 
bleed te varieren. In omstandigheden met een hoge glucagon/ 
insuline verhouding, zeals tijdens vasten of diabetes, is 
de lever lipase aktiviteit laag. Door insuline tezarnen met 
glucose aan gevaste ratten toe te dienen vindt een snelle 
aktivatie van de lever lipase plaats. 
Naast immunologische verschillen tussen de hepatische 
en extrahepatische lipase aktiviteiten, werd ook een ver-
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schil in substraatspecificiteit gevonden. Het lever enzym 
heeft een lagere affiniteit voor een artificiele triglyce-
ride emulsie, maar katalyseert de hydrolyse van palmitoyl-
CoA beter dan extrahepatische lipoproteine lipase. 
Daar in vitro de aktiviteit van het lever enzym bij 
gebruik van hoge concentraties triglyceride die van het 
extrahepatische enzym overtreft lijkt het aannemelijk dat 
oak in vivo de lever zou kunnen bijdragen tot een verlaging 
van het serum triglyceride gehalte vooral indien deze haag 
zou zijn. 11et andere woorden, de lever zou een soort 
11 0Verflow" funktie kunnen vervullen. De rol van de lever 
in de afbraak van serum lipoproteine intermediairen (zoge-
naamde "remnants") werd besproken. De lever lipase lijkt 
een snelheidsbepal~nde faktor hierin te kunnen zijn. 
Voorbehandeling van ratten met een cortisol prepa-
raat en met bepaalde dieten blijkt van invloed te zijn op 
de postheparine serum lipase aktiviteiten van hepatische 
en extrahepatische oorsprong. 
Daar raapzaadolie-rijke voeding bij ratten in een 
vroege fase snel tot hartvervetting leidt, welke op den 
duur weer verrnindert, ~rerd de invloed van deze voeding op 
de (lipoproteine-) lipasen van lever en hart nagegaan. Ge-
vonden werd dat deze enzyrn aktiviteiten toenemen,rnogelijk 
bijdragend tot de verdwijning van excessieve vetstapeling 
uit de hartspier. 
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IDENTITY WITH CLEARING FACTOR LIPASE 
H. JANSEN AND W. C. HULSMANN 
Department of Biochemistry I, Rotterdam Medical School, P.O. Box 1738, Rotterdam (The Netherlands) 
(Received July 28th, 1972) 
SUMMARY 
After intravenous heparin administration, palmitoyl-CoA hydrolase activity 
strongly increases in the blood. The properties of the enzymatic reaction were studied 
and compared with published data on lipoprotein lipase (EC }.1.1.3). In all cases 
striking similarities were obtained. We therefore conclude that serum postheparin 
palmitoyl-CoA hydrolase and lipoprotein lipase are identical. Lipoprotein lipase 
activity in postheparin serum was found to be lowered by fructose feeding. 
INTRODUCTION 
In our studies on carnitine-palmitoyltransferase (hexadecanoyl-CoA: carnitine 
0-hexadecanoyltransferase) long-chain acyl-CoA hydrolase activity frequently inter-
fered. Therefore, we decided to study the long-chain acyl-CoA hydrolase activity more 
closely. In accordance with other investigatorsL4 , we found the main activity to be 
present in the microsomal fraction of liver. On the basis of the observations of Barber 
and Lands5 , who showed that pancreatic lipase is capable of long-chain acyl-CoA 
hydrolysis, we decided to investigate whether lipoprotein lipase can be determined with 
long-chain acyl-CoA as the substrate instead of its conventional triglyceride substrate, 
especially as the conventional specific triglyceride hydrolysis measurements (compare 
Materials and Methods) are rather laborious. 
Hahn6 showed in 1943 that lipoprotein lipase (or clearing factor lipase) is 
released into the bloodstream after the intravenous injection of heparin, part of which 
may be derived from cardiac lipoprotein lipase7 We therefore investigated whether 
postheparin serum contained not only lipoprotein lipase activity, but also long-chain 
acyl-CoA hydrolase activity. It is the purpose of the present investigation to report 
on the presence of both activities and on the identity of the activities. 
Abbreviation: DTNB, 5,5' -dithiobis-(2-nitrobenzoic-acid). 
H. JANSEN, W. C. HOLSMANN 
MATERIALS AND METHODS 
The acyl-CoA esters were made by a slight modification of the method of 
Stoffel et a!. 8 . 
Protein was estimated according to Lowry et a!. 9 . 
For the Epoprotein lipase assay the method of Kelly10 was followed. Incubation 
was carried oat in princjple according to Boberg and Cadson11 . The substrate was 
prepared as follows. About 15 I'Ci of tri-P 4 CJoleylglycerol (Radiochemical Centre, 
Amersham, England), dissolved in benzene, were evaporated to dryness in a plastic 
tube (when g]ass was used, emulsification was less reproducible), ro ml Intralipid 
(Vitrum, Stockholm, Sweden), containing I g triglyceride, o. I2 g ]ecithin, 0.25 g 
glycerol and an emulsifier, were added to the residue and sonicated (7 times for r min 
at 20 kHz, with intermittent cooling in ke). 0.35 ml of the radioactive triglyceride 
emulsion, 2.6 mJ of67 mgjml fatty acid-poor bovine serum albumin (Pentex, Kankakee, 
Ill., U.S.A.) in 0.1 M NH4 OH-NH4Cl buffer of pH 8 and 1.0 mllmman serum (citrate 
plasma dotted by the additllon of Ca2 + and diaJysed) were· incubated for 30 min at 
'7 'C. Then 10 Jtl heparin (5000 l. U.jml = so mgjml, Organon, Oss, The Netherlands) 
~md 0.5 ml enzyme were added. Samples of I ml were removed at IO, 20, 30 and 40 min 
znd extracted with 5 m] isopropanol-H2S04 , as described by Do]e 12 . 3 m1 of the hep-
tane phase were mixed with 0.5 g Amberhte IRA-400 in a scintllUation viaL After r h of 
m:x.:ne the fluid was removed and the resin washed 4 times with hexane. Finally 0.5 mil 
hyamire hydroxide (1 M in methanol) was added, followed by 10 ml toluene with 
:F[uors, and the samp]es were counted. In al] experiments male Wistar rats were used 
with a body weight varying between 240 and 260 g. The activity of p-nitrophenyl-
acetate hydrolase (carboxyl esterase; EC 3. I. I. I), expressed in pmoles p-nitrophenol 
formed per min at 30 °C, was determined according to Huggllngs and Lapides 13 in the 
preseEce of JLo- 5 },;]! eserine. In the standard assays, palm.itoyl-CoA hydrolase activity 
was nneasured at 30 oc in a volume of 1l mil containing IOO mM Tris-HCL 8o J1IVI 
palmitoyl-CoA and 100 ,uNI 5,5' -dithiobis (2-nit:mbenzoic acid) (DTNB) (see Results). 
The palmitoyl-CoA hydrolase activity was expressed in nmo1es of CoASH formed per 
min. An extinction coefficient of I36oo M- 2 • cm- 1 at 4r2 nm was used for the 
s' -thio-z-nitrcbenzoic acid liberated from DTNB by CoASH. 
Purijication of lipoprotein lipase 
40 rats were injected intravenously with I mg heparin (100 I.U.) per kg body 
weight. After 15 min the rats were decapitated and the blood collected in 0.05 voL of 
0.25 M sodium citrate. The blood was centrifuged for 15 min at 3000 x gmax· The clear 
serum (nso ml) was obtained and mixed with 7-5 ml Io% IntraEpid and stirred for 
I o min at 37 oc. The mixture was spun in a swing-out rotor in a refrigerated centrifuge 
for 1 h at 75000 x gmax· The floating layer was collected and the infranatant again 
mixed with 7.5 ml 10% Intralipid and stirred at 37 'C for 10 min. After centrifugation, 
as clescribed above (the infranatant .is designated Fraction I in Table I), the floating 
1ayer was combined with the first one and suspended in ISO ml ammonia buffer 
containing so mM NH40H-NH4Cl (pH 8.5), 10% sucrose and 10 pg heparin per ml 
and again centrifuged as described above. The floating cake was now washed 4 times 
with 20 m] of the ammonia buffer. After washing, the cake was suspended in 9 ml of 
"Fieldings buffer", containing 50 mM NH4 Cl-NH4 0H, 0.5% deoxycholate (w/v), 
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TABLE I 
SIMULTANEOUS PURIFICATION OF PALMITOYL-CoA AND TRIOLEIN HYDROLYTIC 
ACTIVITIES; DEPENDENCE OF ACTIVITY ON SERUM PROTEINS 
The enzyme fractions are obtained and measured as described under Materials and Methods. The 
dependence of palmitoyl-CoA hydrolase activity on preincubation with serum was illustrated by 
mixing 4·5 ml of 0.8 mM palmitoyl-CoA with either 0.5 ml water or preheparin serum. The reactions 
were carried out under standard conditions. The purified enzyme was diluted 5-fold prior to the assay. 
Source of enzyme Preincubation Palmitoyl-CoA Triolein hydrolase 
of palmitoyl-CoA hydrolyse activity activity 
with serum (munitsfmg protein) (munits/mg protein) 
Postheparin serum 4-4 
Postheparin serum + 4-2 10.6 
Fraction I r.8 4·3 
Purified enzyme 12.8 
Purified enzyme + 636 1900 
0.5 mM potassium oleate and 5 Jlg heparin per ml. The suspension was stirred for I h 
at o oc and centrifuged for 1 h at I 6oooo x gmax in a swing-out rotor. The infranatant 
was designated "purified" enzyme (Table I). 
RESULTS 
Standardization of the measurement of palmitoyl-CoA hydrolase activity in serum 
It can be seen from Fig. I that rat serum contains very low palmitoyi-CoA 
hydrolase activity (4.6 munitsjml), which is strongly increased by the intravenous 
administration of heparin (I mgjkg body weight). Serum obtained from blood removed 
6 min after heparin administration contained the highest activity (Fig. 1 ). A similar 
time dependence for triolein hydrolysis in postheparin plasma was observed by 
v{mU/ml~ 
6 9 IS 
min ofter injection 
Fig. I. Release of palmitoyl-CoA hydrolase in blood after heparin injection. At different times, 1 ml 
of blood was withdrawn from a rat injected with heparin. The zero time sample was obtained by 
withdrawing blood prior to heparin injection. The hydrolase activity was measured under standard 
conditions, as described in the text. The data are the mean values of 5 experiments; the standard 
deviation is shown in the figure. 
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Fielding15 For these reasons serum was generally obtained from blood withdrawn 
6 min after heparin injection. 
Fig. 2 illustrates that the palmitoyl-CoA hydrolase activity in serum is strongly 
pH-dependent. The activity at pH 8.5 is almost optimal, which led us to choose this 
pH for further determinations, since at pH values higher than 9, non-enzymatic 
palmitoyi-CoA hydrolysis becomes significant. 
'·' '·' 
IQ.O 
,ul '"'"'" 
Fig. 2. pH dependence of the palmitoyl-CoA hydrolase activity. In the standard assay the pH of the 
Tris-HCI buffer was varied between 6.5 and 9-5· The extinction coefficient for DTNB was constant 
between pH 7 and 9· 
Fig. 3- Relation between palmitoyl-CoA hydrolase activity and the concentration of protein. In the as-
says (under standard conditions) the sample volume was varied between 3 and 20 pi serum. 
The enzymatic reaction was found to follow zero order kinetics up to 20 ,ul 
serum per ml of incubation medium (Fig. 3). If higher serum concentrations were used, 
lower specific activities were observed, probably because the concentration palmitoyl-
CoA is lowered by adsorption to protein (compare also ref. 2, in which a similar 
v(mU/ml) 
200 
100 
100 200 300 
" 
• 
0 20 40 60 80 
-I 1; [Polmitoyi-CoA] (mM ) 
Fig. 4· Lineweaver-Burk plot ofpalmitoyl-CoA hydrolysis with varying palmitoyl-CoA concentration. 
At standard conditions (see text) the palmitoyl-CoA concentration was varied between 12.5 and 
260 J1M. 
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behaviour was observed with long-chain acyl-CoA hydrolysis catalyzed by rat liver 
microsomes). In our standard assays we used 5 .ul serum per ml incubation medium. 
From Lineweaver-Burk plots (Fig. 4) an apparent Km for palmitoyi-CoA of 
15 jiM could be calculated. Substrate inhibition occurs at a palmitoyl-CoA con-
centration higher than r2o ,uM (see insert of Fig. 4). For these reasons we used in our 
assays a palmitoyi-CoA concentration of 8o jiM. The reaction rate was not influenced 
when the DTNB concentration was varied between 25 and 400 I'M. We have chosen 
a concentration of DTNB in our standard assays of 1 oo I'M. 
Different acyi-CoA esters were tested as substrates under the above conditions 
(51'1 postheparin serum, pH 8.5, 8o I'M acyl-CoA and roo I'M DTNB). No detectable 
activity was observed with acetyl-CoA, propionyl-CoA, butyryi-CoA, hexanoyl-CoA 
and octanoy!-CoA. With decanoyl-CoA, lauroyl-CoA, myristoyl-CoA or palmitoyl-
CoA, increasing activities, in the order given, were found (data not shown). 
Resemblances of the properties of post heparin lipoprotein lipase and postheparin palmit-
oy/-CoA hydrolase 
Kom7 described in 1955 a number of specific properties of clearing factor 
(postheparin) lipase (the activity of which was measured with a coconut oil emulsion 
as the substrate). 
(I) Release of lipoprotein lipase activity in the blood after heparin administra-
tion. This holds also for palmitoyi-CoA hydrolase activity (Fig. 1). (2) Inhibition of 
lipoprotein lipase activity by high NaCl concentration. From Table II it can be seen 
that this is also true for postheparin palmitoyl-CoA hydrolase. (3) Requirement of 
lipoprotein lipase for serum proteins (compare also ref. 14). The serum dependence is 
very clear after purification of the enzyme according to Fielding15 (compare also 
Yasuoka and Fujii16). We did not carry out the last step and obtained significant 
activity in the palmitoyl-CoA hydrolase assay only after preincubation of the substrate 
with preheparin serum (Table I). It can also be concluded from this table that, 
TABLE II 
INHIBITION OF POSTHEPARIN PALM!TOYL-CoA HYDROLASE BY NaCl AND HEPARIN 
Postheparin serum was tested under standard conditions (see text). 
Additions 
None 
I M NaCl 
100 fl.g heparin 
2 so 1-lg heparin 
Activity (munitsfml) 
214 
17 
170 
130 
together with palmitoyl-CoA hydrolase, triolein hydrolase activity was purified. The 
activity in crude postheparin serum was not strongly stimulated by the addition of 
preheparin serum. (4) Requirement of lipoprotein lipase activity for low concentra-
tions of heparin. We were not able to show, under the standard conditions of the 
palmitoyl-CoA hydrolase assay, the stimulatory effect of low concentrations of he-
parin. However, we were able to show that chromatography of postheparin serum on 
Sephadex G-2oo, as has been carried out previously by Yasuoka and Fujii17 , yielded 
no detectable palmitoyl-CoA hydrolase activity in the various eluate fractions (result 
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Fig. 5· Gel filtration ofpostheparin serum. Gel filtration was carried out on a Sephadex G-2oo column 
{5.0 em x so em). 5 ml postheparin serum were chromatographed at 4 oc. The flow rate was 15 ml/h. 
Samples of 8 ml were collected. In the samples, protein was estimated according to Lowry et a!. 9 ; 
p-nitrophenylacetate hydrolase (carboxyl esterase) and pa\mitoyl-CoA hydrolase activities were 
measured as described in the text. The elution buffer was so mM NH4 Cl-NH4 0H at pH 8.5, con-
taining heparin when indicated. 
not shown), unless 5 }lg heparin per ml elution buffer was present (Fig. 5). The pal-
mitoyl-CoA hydrolase peak corresponds close to the lipoprotein lipase peak obtained 
by Yasuoka and Fujii17 , and is different from the carboxyl esterase peak (Fig. 5). 
When the fractions obtained without heparin in the elution medium (top of Fig. 5) 
were incubated with heparin, the hydrolase activity was not restored. (5) Inhibition of 
lipoprotein lipase activity by excess heparin. The inhibition by heparin is also observed 
when palmitoyi-CoA is the substrate (Table H). 
Post heparin serum and its hydrolytic activities towards triolein and palmitoyl-CoA 
From Table HI it can be concluded that the ratio of the hydrolytic activities 
towards triolein and palmitoyi-CoA does not vary considerably with different enzyme 
samples, indicating that variation of lipoprotein lipase activity in different sera may be 
detected with either method. 
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TABLE IH 
COMPARISON OF TRIOLEIN AND PALM!TOYL-CoA HYDROLYSIS IN VARIOUS 
I'OSTHEPAR!N SERA 
247 
Rats were fed for 40 h with different diets as indicated. Control rats were fed with normal laboratory 
chow. The casein diet contained 85% casein, HO% crisco, I %vitamins and 4% salt mixture. "fbe 
fructose diet contained I7% casein, 68% fructose, ro% crisco, I% vitamins and 4% salt mixture. 
After heparin injection the rates of hydrolysis of pa!mitoyl~CoA m triolein were measured in the 
obtained sera, as described in the text. The rate oftriioldn hydrolysis is expressed as nmoles fatty acid 
formed per min per ml serum. The palmi.toyl-CoA hydro1ase activity is expressed as munits/ml 
serum. The average of two experiments is given. 
Conditions of 
the rats 
Control diet 
Control diet 
Casein diet 
Fructose diet 
Blood withdrawn 
after (min) 
6 
IS 
6 
6 
Substrate 
Triolein 
720 
573 
7I7 
448 
Activity ratio 
Palmitoyl~CaA 
277 2.6 
229 2.5 
z68 2.7 
I 56 2.9 
-----~~~~--~~~~~~-~~~~~~~~-
DISCUSSiON 
From the results obtained it seems very likely that postheparin lipase and post-
hepar]n pa~mitoyl-CoA hydrdase in serum are identic:at The determination vvith 
palm-itoyl-CoA as the substrm:e requires ody small amounts of enzyme, whllch may be 
of advantage in cases where the amounts to be obtained are small Another advantage 
is the simple procedure in which continuous recording is uossibie. Moreover<there ts 
no need f~r preincubation of the substrate with contrd (pr~heparin) serum, v;h]ch may 
influence the resuLts. Although the data with both methods, as shown in Tables I and 
1H, correspond fairly well, it is conceivable that in certain situations good correlation 
is net seen when the activating factors are rate hmiting, That in the postheparin 
paJmitoyl-CoA hydrolase reaction activating serum factors are also needed was 
demonstrated in Tabie I. Th~s can also be ]nferred from experiments (not shown) in 
which less than 5 ,ul serum were used. Jn those cases we regulady observed a bg phase in 
the spectrophotometric assay, probably due to "serum activation". That the hydrolytic 
activity, presently studied, requires serum protefins for activity, may be of importance 
in further studies wjth tissue homogenates in which not on]y the hpoprotein lipase, 
but also other lipases, may contribute to palmitoyl-CoA hydro]ysis. Pancreas, for 
instance, contains palmitoyl-CoA bydrohse activity which is not serum dependent5 . 
Kurooka et a!. 18 found ir: kidney, Ever, sp]een, testis, heart brain and erythrocytes 
considerable llong-chain thioesterase activity in the absence of added senJm. 
Future distribution studies of _palmitoyl-CoA hydrolases in various organs win make 
use of the properties described in the present paper as wen of inhibitors, of which 
paraoxon was found to inhibit hpo_protein lipase (as weH as postheparin palmitoyl-
CoA hydrolase) at a concentration of I0- 5 M. It shou]d b-e mentioned that., after 
heparin injection, palmitoyl-CoA hydrolase activity appears not only in rat but also 
in humans (data not given). 
In an attempt to obtain different lipoprotein lipase activities in sera, in order 
to find out whether the activity as measured with palmitoyl-CoA as the substrate 
correlated with the activity with triglyceride as the Substrate, we investigated the 
influence of fructose in the diet. In an earlier study19, it was found that fructose stim-
H. JANSEN, W. C. HDLSMANN 
ulated the resorption of fat from the diet. As was shown in Table III fructose feeding 
led to decteased lipoprotein lipase activity. This phenomenon might contribute to the 
fructose-induced increase in serum triglyceride levels as observed by McDonald20 
under certain conditions. 
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SUMMARY: Lipoprotein lipase activity was purified from rat posthe-
parin serum. An antibody against this activity was raised. It was 
found that this antibody inhibits 957. of the postheparin lipopro-
tein lipase activity. The same inhibition was found in the perfu-
sate of heparin-perfused rat liver. When measuring lipoprotein li-
pase activity in perfusates of rat hearts, perfused with heparin, 
no inhibition by this antibody was found. It is concluded that li-
poprotein lipase activities from heart and liver are catalysed by 
different enzymes and that the heart enzyme contributes not more 
than 57. to the overall lipase activity in postheparin serum. 
Korn (l) showed in 1955 that acetone powders of rat heart con-
tained lipoprotein lipase. This enzyme is known also to be localized 
in lung, adipose tissue, diaphragm and mammary gland. After intra-
venous injection of heparin, lipoprotein lipase activity appears in 
the blood (2). This activity is assumed to be released from extra-
hepatic organs. However a number of authors (3,4,5) have shown re-
cently that lipase activity is also released from the liver. Borensz-
tajn et al. (6) had found that a large part of the original lipopro-
tein lipase activity was removed from the heart after perfusion of 
rat heart with a heparin containing medium. Liver shows a very rapid 
release of lipase activity on perfusion with heparin. Therefore we 
investigated the contributions of liver and heart to the lipase acti-
vity of postheparin plasma. 
METHODS 
Rats were injected with heparin (100 I.U./kg bodyweight). After 6-
15 min they were killed and the blood was collected. Lipoprotein li-
pase activity was purified from the serum on a sepharose-heparin co-
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lumn, as described for lipoprotein lipase from skim milk by Olive-
crena and Egelrud (7). We replaced the NaCl gradient by a heparin 
gradient (0-1.25 mg/ml). The purification was 600-fold. In a subse-
quent calciumphosphate adsorption step another two-fold purifica-
tion was obtained, 1 mg of the purified enzyme, mixed with Freunds 
adjuvant (1 :1), was injected in the foot pads of a rabbit. After 4 
weeks a booster injection was given intramuscularly and 10 days la-
ter 30 ml blood was collected by heart punction. Purification of the 
y-globulin fraction was achieved by ammonium sulphate precipitation 
(50% saturation) and gel filtration on a Sephadex G-200 column, fol-
lowed by another ammonium sulphate precipitation. Electrophoresis 
(not shown) indicated that the isolated fraction contained only y-glo-
bulins. Serum of a non-immunised rabbit was handled in the same way. 
This y-globulin fraction was used in control experiments. 
Rat hearts were perfused, after Nembutal narcose of the animals, 
according to the L~ngendorff technique with a modified Tyrode solu-
tion for 10 min at 37°C. Then the perfusion medium was replaced by 
one containing, in addition, 20% (v/v) preheparin rat serum and 4.5 
I.U. heparin/mi. 
Rat livers (about 8 g) were perfused through the portal vein with 
a Krebs-Henseleit bicarbonate buffer, saturated with 95% 0 2 - 5% co 2 , 
containing 5 mM glucose at 33 + 2°C. The inferior caval vein was liga-
ted below the liver and cannulated above the liver. After 10 min per-
fusion at a rate of 20 ml/min the perfusion medium was replaced by 
a medium, containing 80% of the medium described above and 20% of rat 
serum (v/v) as well as heparin (final concentration 4.5 I.U./ml). The 
top of the latter was briefly sprayed with Antifoam (Dow Corning Corp.). 
Lipoprotein lipase activity was estimated with palmitoyl-CoA as the 
substrate, as described by Jansen and Hiilsmann (8). When [ 14 c] trioleate 
was used as the substrate, the modified method of Kelly, as descri-
Table I 
INFLUENCE OF PREHEPARIN SERUM ON PURIFIED AND ANTIBODY TREATED LIPOPROTEIN LIPASE 
Enzyme source Preincubation* 
Purified enzyme none 
" " 
none 
" " 
none 
Postheparin serum 60 min, no additions 
" " 
60 min, IS ~1 control y-glob. 
fraction present 
" " 
60 min, IS ~1 control y-g1ob. 
fraction present 
" " 
60 min, IS ~1 control y-g1ob. 
fraction + I 0 ~1 human 
serum present 
" " 
60 min, 15 ~1 antibody fraction 
present 
" " 
60 min, 15 ~1 antibody fraction 
present 
" " 
60 min, 15 ~1 antibody fraction 
+ I 0 ~1 human serum present 
Incubations were carried out as described in Fig. I • The 
Additions to 
standard assay 
none 
I 0 ~1 human serum 
10 ~l rat serum 
none 
none 
I 0 ~1 human serum 
none 
none 
I 0 ~1 human serum 
none 
blood was withdrawn 6 min 
jection and centrifuged; the plasma was tested. Palmitoyl-CoA was the substrate. 
Activity 
1200 mU/mg 
186S mU/mg 
1880 mU/mg 
140 mU/ml 
136 mU/ml 
148 mU/ml 
143 mU/ml 
7 mU/ml 
6 mU/ml 
8 mU/ml 
after heparin in-
*where shown, incubation of 5 ~1 postheparin serum was for 60 min at 37°C, followed by centrifugation 
for 2 min at 15 000 x ~· 
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Fig. 1 . Influence of different amounts of antibody and different 
incubation times on postheparin lipoprotein lipase acti-
vity. 
20 ~1 postheparin plasma was either incubated for h with 
different amounts of antibody- or control preparation at 
37°C (Fig. IA) or at different incubation times, as shown 
in Fig. lB. The mixtures were centrifuged for 2 min at 
15 000 x g. From the supernatants amounts equivalent to 
5 ul origTnal postheparin serum were tested, The amounts 
of control- or antibody preparation used were related to 
5 Ul postheparin serum. 
bed in ref. 8, was used. Activities are expressed as nmoles CoASH re-
leased per min in the palmitoyl-CoA assay, and as nmoles FFA released/ 
min, when trioleate was the substrate. 
RESULTS 
The antibody preparation was diluted with 0.9% NaCl to a protein 
concentration of 3.35 mg/ml, the same was done with the control serum 
fraction. By varying the antibody concentration and the incubation 
time we found that 15 ~1 antibody inhibited lipoprotein lipase activi-
ty of 5 ~1 whole postheparin serum 95%, when incubated between 30 and 
60 min at 37°C, followed by centrifugation for 2 min at 15 000 x ~ 
(Fig. lA and B). The presented values are based on linear reaction 
rates measured during the first tO min. In order to exclude that an 
enzyme labile at 37°C was inactivated during the incubation with con-
trol or antibody, we incubated postheparin serum with a non-saturating 
amount of control and antibody at 0°, 37° and 40°C. It was found that 
during the incubation at 0°C for 3.5 h no activity was lost and that 
Vol. 55, No. 1, 1973 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
with this amount of antibody 707. of the initial activity was inhibited. 
Incubation at 37°C gave a loss of. 19% of the initial activity; of the 
remaining activity 70% was again inhibited by the antibody. Incubation 
for 1 h at 40°C with control y-globulins resulted in 75% inactivation 
of the enzyme. The remaining activity was again 70% inhibited by the 
antibody. Therefore the existence of a heat-labile non-inhibited enzyme 
could be excluded. 
In order to exclude that the inhibition resulted from antibody 
against activating proteins, we incubated antiserum together with pre-
heparin human serum (preheparin human serum showed no precipitation li-
nes in the Ouchterlony immune diffusion assay with the antiserum) 
and added human serum to the inhibited enzyme. Table I shows that the 
addition of human serum before or after incubation with antiserum 
does not influence the reaction rate. It is also shown that the par-
tially purified enzyme is activated in the same way by human serum 
as by rat serum. In another experiment (not shown) whole antiserum 
was mixed with preheparin rat serum and the resulting precipitate re-
moved by centrifugation. From the supernatant, y-globulins were puri-
fied as described before. It was found that with this preparation the 
same results were obtained as with the original y-globulin fraction. 
From this and from Table I it can be concluded that the antibody in-
hibits the enzyme directly and that the inhibition is not caused by 
precipitation of activating plasma proteins. 
In order to detect the principal source of lipase activity in post-
heparin serum, liver and heart were perfused in vitro with a heparin 
containing medium (Table II). It was found that lipoprotein lipase 
activity released from rat heart did not interact with the antibody, 
but that the liver perfusate is inhibited to the same extent as the 
postheparin serum lipase activity. After incubation for a longer time 
(60 min 37°C) the activity of the liver perfusate is completely inhi-
Table II 
INHIBITION OF POSTHEPARIN SERUM-, HEART- AND LIVER LIPASE ACTIVITIES BY ANTIBODY AGAINST 
POSTHEPARIN SERUM LIPASE 
Enzyme source Pretreatment 
with 
control antibody 
Po s thepar in serum + -
" " 
- + 
Heart perfusate + -
" " 
- + 
Liver perfusate + -
" " 
- + 
Lipoprotein lipase activity 
substrate used 
palmitoyl-CoA 
(mU/ml) 
148 
21 
7.4 
7 . 4 
I I 4 
19 
trioleate 
(nmoles/min/ 
ml) 
318 
68 
3.7 
3. 7 
29.0 
4. 5 
% Inhibition 
substrate used 
palmitoyl-CoA trioleate 
86 78 
0 0 
83 84 
Liver and hearts were perfused as described. Fractions of 10 ml were collected. Most of the 
activity in the liver was released in the first 2 min (=40 ml). The heart released its ac-
tivity more gradually; during 6 min (=60 ml) equal activities were obtained. Pretreatment 
of the perfusates was as described in Fig. I, Incubations were done for 30 min at 37°C. 
5 ~1 postheparin serum was incubated with 15 ~1 antiserum. Heart-and liver perfusates were 
incubated with equal volumes of anti- or control serum. 
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bited (not shown), whereas the lipase activity of postheparin serum 
is inhibited 95% (Fig. IB). 
DISCUSSION 
From the data obtained it can be concluded that lipase activities 
that are released by heparin from heart and liver are catalysed by 
immunologically different enzymes. The lipase activity in serum, after 
heparin injection, behaves very similarly to the liver enzyme in respon-
se to the inhibitory action of the antibody (Table II). In this table 
it can be seen that the inhibition of postheparin serum lipase by the 
antibody, when measured with trioleate as the substrate, is 8% less 
than when palmitoyl-CoA is the substrate. This can be explained by 
the higher ratio of palmitoyl-CoA hydrolase activity over trioleate 
hydrolase activity in liver perfusate, when compared with heart per-
fusate. The data obtained in Table I allow the conclusion that the 
heart contributes maximally 5% to the lipase activity in postheparin 
plasma, when palmitoyl-CoA is the substrate, and not more than 13% 
when trioleate is the substrate. Kraus et al. (5) found, that about 
65% of the lipase activity in postheparin serum was derived from the 
liver. It is tempting to conclude from our results that even up to 
95% (87% with trioleate as the substrate) of the lipase activity is 
released by the liver. It is possible that we find a somewhat higher 
contribution by the liver because we used a smaller amount of heparin 
[100 I.U. vs. 250 I.U./kg body weight used by Kraus et al. (5)]. 
Another explanation would be that, in addition to heart and liver, 
other organs contribute to the serum activity and that this activity 
would be equally inhibited by the antibody. This is presently under 
investigation. It has already been found, that the purified postheparin 
serum enzyme showed only one protein band with hydrolase activity in 
polyacrylamide gel electrophoresis (pH 8.9) (not shown). Fielding (4) 
found that the liver enzyme had a different substrate specificity 
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than the activity released from other organs. The present paper shows, 
that this difference (at least for heart and liver) is due to diffe-
rent enzymes and not only to the influence of cofactors, as was dis-
cussed before by LaRosa et al. (3) and Kraus et al. (5). 
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Summary 
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The influence of the amount of heparin injected on the contributions of 
liver and of extrahepatic tissues to the lipase activity of postheparin serum of 
the rat was studied. It was found that when high doses of heparin (20 I.U./100 
g bodyweight) were injected, the liver contributes for 63% to the total triacyl-
glycerol lipase activity of postheparin serum. At low heparin levels (0.4 
I.U./100 g bodyweight) the lipase activity in the postheparin serum is almost 
solely derived from the extrahepatic tissues. The activity of the liver enzyme in 
the postheparin serum was found to increase very fast after heparin injection. 2 
min after heparin injection a maximum activity of the liver enzyme in the 
serum was found. Subsequently the liver enzyme is removed from the circula-
tion. Not only the activity of the liver enzyme is dependent on the amount of 
heparin injected, but also the amount of enzyme released from the liver. 
Fat feeding increases the hydrolytic activity released from the liver by 
heparin. Immunological studies suggest that the enzyme may be in a more 
active state. The role of the heparin-releasable liver enzyme in fat metabolism is 
discussed. 
Introduction 
After intravenous injection of heparin, lipase activity is released into the 
bloodstream [1]. The enzyme activity is released from different organs. Two 
species of triacylglycerol lipase activity have been characterized in postheparin 
serum, differing in substrate specificity and in sensitivity to some inhibitors, 
such as high concentrations of salt and protamine sulfate [2,3]. At least two 
activities are found to be immunologically different [ 4] and to be released 
from liver and extrahepatic organs, respectively [ 4] . The extrahepatic activity 
is accepted to be identical with lipoprotein lipase as defined by Kom [ 5] . The 
role of this heparin-releasable activity is the hydrolysis of serum triacylgl0 cerols 
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[6,7], and therefore involved in the utilization of serum triacylglycerols by 
these extrahepatic organs. The role of the heparin-releasable liver enzyme is 
much less clear. Maybe that in vivo the lipase activity of the liver is mainly 
directed towards fatty acid esters other than triacylglycerols, although the 
postheparin liver enzyme definitely hydrolyzes serum triacylglycerols in vitro 
[3]. Indeed, liver releases also phospholipase [8] and monoacylglycerollipase 
[9] activities after heparin perfusion. That some lipase and phospholipase activ-
ities in postheparin serum may be identical has been suggested already in 1965 
by Vogel and Bierman [10]. They showed that in postheparin serum a protein 
is found with lipase and phospholipase activities which are not separable by 
electrophoresis, ultracentrifugation or gelfiltration on Sephadex G-200. The 
liver enzyme may contribute considerably to the overall postheparin serum 
lipase activity [2-4], the magnitude of which may vary to a large extent. 
Therefore, we studied some factors that could influence the contribution of the 
liver lipase activity to the serum, such as the amount of heparin injected and 
the time of blood collection after heparin injection. Another possible influence 
studied was the effect of fat feeding since previous work [11] indicated that 
after 6 days rapeseed oil feeding the lipoprotein lipase activity of postheparin 
serum is elevated when compared with olive oil feeding. Houtsmuller et a!. 
[12] showed that rapeseed oil feeding results in a maximal triacylglycerol 
accumulation in rat heart after 3 to 4 days and that after 6 days the triacylgly-
cerol content decreases rapidly. We [11] have, therefore, suggested that the 
increased postheparin lipase activity found after 6 days feeding might be 
related to the decrease of the triacylglycerol content of the heart. For that 
reason we raised the questions: is the increased serum activity after 6 days 
rapeseed oil feeding of extrahepatic or of hepatic origin and, secondly, is the 
increased activity due to enzyme activation or an increased synthesis of enzyme 
protein? Both questions can be answered by immunological studies as will be 
presented. 
Methods 
The lipase activity in the postheparin serum was measured with palmitoyl-
CoA or Intralipid as the substrate as described before [13]. In the feeding 
experiments the rats had free access to water and food unless stated otherwise. 
The rapeseed oil diet consisted of 50 cal % rapeseed oil ( 48% C22 : 1). The 
olive oil diet was composed of 50 cal % olive oil. In contrast to the earlier 
studies [11] on the connection between lipoprotein lipase and rapeseed oil 
feeding, the rats were not fasted overnight before use, unless stated different. 
In all experiments male Wistar rats were used. Their weights ranged from 
210 ± 30 g. The heparin injections were made intravenously under Nembutal 
narcosis between 9 and 11 a.m. 
Acetonepowders of different organs were prepared as. described by 
Borensztajn et a!. [14] and extracted with 25 mM NH4 OH-HCl buffer (pH 
8.5). Total hepatectomy was achieved under ethernarcosis by a two-stage pro-
cedure. In the first stage 65-7 5% of the liver was removed according to Higgins 
and Anderson [15]. Subsequently a porta-cava shunt was made as described by 
Fisher and Lee [16]. After the operation the rats were allowed to recover for 
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30 min. Then 50 I.U. heparin (Organon, Oss, The Netherlands) were injected 
intravenously and blood was withdrawn 2 min later. 
Differentiation between liver and extrahepatic lipases in postheparin serum 
In the postheparin sera the lipase activity released from the liver was 
determined with the help of an antibody against this activity. The antibody was 
raised as described previously [ 4]. The specificity of the antibody was ex-
tended to other organs as is shown under Results (Table I). The incubations of 
the postheparin sera with the antiserum were carried out in principle as de-
scribed in ref. 4. The incubation temperature, however, was lowered to 0° C to 
avoid inactivation of the extrahepatic enzyme. It was found that during 14 h of 
incubation at 0° C the total lipase activity of postheparin serum in the absence 
or presence of serum of a non-immunized rabbit (control serum) was stable. 
The inhibition by the antiserum was already maximal after about 4 h. The 
postheparin sera were routinely incubated with an excess of antiserum (1 : 2, 
v/v) for 14 h at 0°C. An increase of the amount of antiserum or incubation 
time did not result in a further inhibition of the lipase activity in postheparin 
serum. After the incubation the mixtures were centrifuged for 2 min at 15 000 
X g and the activities measured in the supernatant. The amount of lipase 
activity inhibited is taken as the contribution of the liver to the total lipase 
activity of the postheparin sera. The rabbit sera used, were always preincubated 
for 1 h at 56° C in order to inactivate lipase activities possibly present in these 
sera. In the experiments shown in Fig. 1 and Table VII, antiserum, bound to 
Sepharose as described by Neuwelt eta!. [17], was used. 
Estimation of the "specific activity"* of the inhibited enzyme 
In order to estimate the "specific activity" of the liver enzyme the en-
zyme activity that could be bound to Sepharose-linked antiserum was mea-
sured. In Fig. 1 a typical experiment is shown. A constant amount of Sepha-
mu 
A 
' 
3 0 
2 
30 
pl·posth~parin serum 
Fig. 1. Relationship between hydrolytic activity and the amount of immunoreactive protein of liver 
lipase. Each point represents the mean value of duplicate experiments with the serum of a rapeseed oil-fed 
rat. The experiments were carried out as described under Methods. 
* The activity inhibited by a certain amount of antiserum. 
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rose-linked antiserum was incubated with different amounts of postheparin 
serum. The activity of the unbound enzyme was measured in the supernatant 
after centrifugation at low speed. The measured activity was plotted against the 
amount of serum incubated (closed circles). In control experiments the same 
incubations were carried out with Sepharose bound to serum of a non-
immunized rabbit (Line A, open circles). Fig. 1 shows that at lower serum 
concentrations in the presence of a fixed amount of antiserum, the activity 
increases in a linear fashion with the amount of serum added. This activity 
must be of extrahepatic origin. At higher serum concentrations, however, the 
antiserum is saturated with the enzyme of hepatic origin and therefore the 
latter as well as enzyme(s) of extrahepatic origin will contribute to the activity, 
so that an upward inflection can be observed (Fig. 1, closed circles). By extra-
polation of the initial part of the curve (Line B) and subtraction of the cal-
culated extrahepatic activities from the activities measured at higher serum 
concentrations (closed circles), a curve can be constructed (Line C), which 
presents the activity of the hepatic contribution at the serum concentration 
plotted on the abscissa. By extrapolation of Line C an intersection with the 
abscissa is obtained, the value of which represents the maximal amount of 
serum of which all (liver) activity is bound by the amount of antibody used. 
The corresponding (liver) activity of that amount of serum can be calculated. 
Results 
Specificity of the antiserum 
In order to test the specificity of the antisera, lipase activities of acetone-
powder extracts of different organs were measured after preincubation with 
serum of a non-immunized rabbit (control serum) or antiserum. In Table I it 
can be seen that while the liver activity is completely inhibited, the lipase 
activities of the other organs are not influenced by the antiserum. Previously 
[ 4] we reported that also the lipase activity of in vitro obtained perfusates of 
rat liver was abolished completely by the antiserum, while heart perfusates 
were unaffected. In order to study also the in vivo released lipase activities of 
extrahepatic organs, two rats were hepatectomized as described under Methods. 
TABLE I 
INHIBITION OF LIPASE ACTIVITIES FROM DIFFERENT SOURCES BY THE ANTISERUM 
Acetonepowder extracts of different organs were diluted with buffer so that every extract contained the 
same order of lipase activity per ml. Then the extracts were incubated with control- or antiserum. Lipase 
activities were measured with Intralipid as the substrate and expressed in nmoles free fatty acid released/ 
min per ml extract. 
Enzyme source Activity after incubation with 
Control serum Antiserum 
Liver 14 0 
Lung 28 28 
Heart 34 33 
Adipose tissue 27 28 
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It was found that the antiserum did not influence the lipase activity of the 
serum of these rats after injection of 50 I.U. heparin when either palmitoyl-
CoA or Intralipid was used as the substrate. From these data it is concluded 
that the antiserum is inactive against extrahepatic lipases and that the activity 
released from the liver is completely inhibited. 
Influence of the amount of heparin injected and time of bloodremoval on 
post heparin lipase activity of hepatic origin 
The influence of the amount of heparin injected on the contributions of 
the liver and extrahepatic organs to the total serum triacylglycerol hydrolase 
activity is shown in Table II. Apparently the activity displayed by the liver 
enzyme depends on the amount of heparin injected. The extrahepatic con-
tribution seems to be released at lower heparin concentrations and relatively 
little influenced by the injection of the higher heparin concentrations. In these 
experiments blood was withdrawn 2 min after heparin injection. Earlier we 
have found with isolated perfused rat liver that the bulk of the heparin·releas· 
able activity is released within 2 min. From the experiments of Table III it can 
be concluded that indeed in the intact rat also, the hepatic contribution to the 
total serum activity is higher at 2 min after the injection of 50 I.U. heparin 
than at 6 min and that the hepatic contribution beyond this time declines 
significantly. This contrasts the extrahepatic contribution which remains rela-
tively constant between 2 and 20 min after injection. A similar picture was 
obtained when the lipase activity in the serum was tested with palmitoyl·CoA 
as the substrate (ref. 13) instead of trioleylglycerol (cf. also Table IV). With 
palmitoyl-CoA as the substrate the liver contribution to the hydrolytic activity 
of postheparin serum was much larger than with trioleylglycerol as the sub· 
strate (compare Tables III and IV) In other words, the hepatic contribution to 
postheparin serum lipase can hydrolyse both palmitoyl-CoA and trioleate effi-
ciently, whereas the extrahepatic contribution preferentially hydrolyses tri-
oleylglycerol and has little activity towards palmitoyi·CoA. In a large series of 
experiments the latter could be verified (not shown). 
TABLE II 
INFLUENCE OF THE AMOUNT OF HEPARIN INJECTED ON THE CONTRIBUTIONS OF LIVER 
AND OTHER ORGANS TO THE LIPASE ACTIVITY IN POSTHEPARIN* SERUM 
Four groups of five rats were in.iected intravenously with 1, 5, 25 or 50 I.U. heparin, respectively. 2 min 
after the injection the rats were killed and the blood collected. In the serum the contributions of the liver 
and extrahepatic organs to the total lipase activity was estimated as described under Methods. Lipase 
activity was measured with "lntralipid" as the substrate. The activities are expressed in nmoles free fatty 
acid released/min per ml ± S.E. 
Amount Lipase activity Percentage 
of heparin liver-
injected Hepatic Extrahepatic activities 
1 2± 2 65 ± 17 3 
5 55± 8 80 ± 14 41 
25 172 ± 14 120 ± 16 59 
50 200 ± 15 115± 7 63 
* The lipase activity of preheparin rat serum were found to be negligible. 
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TABLE Ill 
INFLUENCE OF THE TIME OF BLOOD WITHDRAWAL AFTER HEPARIN INJECTION ON THE 
CONTRIBUTIONS OF THE LIVER AND EXTRAHEPATIC ORGANS TO THE TOTAL LIPASE 
ACTIVITY IN POSTHEPARIN SERUM 
Five rats were injected with 50 I. U. of heparin. 1 ml of blood was withdrawn from each rat at 2, 6 and 
20 min after the heparin injection. In the sera the co~tributions of the liver and the extrahepatic organs 
to the total lipase activity of the serum was estimated as described under Methods. "Intralipid" was the 
substrate. The activity is expressed as nmoles free fatty acid released/min per ml ± S.E. 
Blood withdrawn Lipase activity Contribution of the 
after heparin liver to the total 
injection (min) Hepatic Extrahepatic lipase activities(%) 
2 194 ± 16 116 ± 14 63 
6 165 ± 7 118 ± 13 60 
20 99 ± 14 106 ± 11 48 
From Tables II and III it can be concluded that when relatively high 
concentrations of heparin are used a large part of the postheparin lipolytic 
activity is of hepatic origin and that the activity rapidly decreases when the 
removal of blood from the animal is delayed. Subsequently we investigated 
whether the disappearance of the activity from the bloodstream is due to 
inactivation of the enzyme, i.e. whether the ratio of active vs. inactive enzyme 
in the blood would decline, or whether enzyme protein active or inactive would 
disappear from the bloodstream by e.g. uptake in the liver (compare refs. 21 
and 22). Therefore, rats were injected with different amounts of heparin and 
blood removed at different times. It can be seen from Table IV that delayed 
removal of blood causes a decrease of the liver contribution to postheparin 
lipolytic activity and that the amount of antiserum required to inhibit one 
munit of enzyme activity remains fairly constant. This indicates that enzyme 
protein completely disappears from the bloodstream and that not inactive, 
TABLE IV 
PALMITOYL-CoA HYDROLASE ACTIVITY IN POSTHEPARIN RAT SERA; INFLUENCE OF RABBIT 
ANTI RAT LIVER SERUM 
Rats were injected with either 50 I. U. or 20 I. U. heparin as indicated. Blood was withdrawn at various 
times after the injection. In the sera the hepatic palmitoyl-CoA hydrolase activity was estimated as 
described under Methods. By varying the antiserum concentration at a constant rat serum concentration 
the amount of antiserum that inhibited 50% of the liver activity was estimated. From the data obtained 
the palmitoyl-CoA nydrolase activity that was inhibited by 1 ,ul antiserum was calculated. Activities are 
expressed in nmoles CoASH released/min per ml. 
Heparin Blood with- Hydrolase activity Activity 
injection drawn after inhibited (1. U.) (min) Hepatic Extrahepatic by 1 ,ul 
antiserum 
(munits) 
50 2 281 18 0.32 
30 162 28 0.33 
20 2 120 21 0.33 
20 52 20 0.30 
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TABLE V 
CONTRIBUTIONS OF LIVER AND EXTRAHEPATIC ORGANS TO THE HYDROLASE ACTIVITY OF 
POSTHEPARIN SERUM OF RATS FED ON VARIOUS DIETS AFTER A 16-h FASTING PERIOD 
Rats were fed during 10 days on various diets (see under Methods). After this period the rats were fasted 
for 16 h. Then heparin was injected intravenously (10 I.U./100 g body weight). After 6 min blood was 
withdrawn. Hepatic and extrahepatic contributions were estimated as described under Methods. Activities 
are expressed in nmoles palmitoyl-CoA hyfuolyzed/min per ml serum ± S.E. 
Diet 
Laboratory chow 
Olive oil 
Rapeseed oil 
Number 
of rats 
4 
6 
7 
Hydrolase activity in the serum 
Total Hepatic Extn>hepatic 
147 ± 7 105 ± 5a 42 ± 2d 
139 ± 13 107 ± ub 32 ± 28 
180 ± 10 140 ± 8' 40 ± zi 
Statistically significant difference between a and c: 0.02 >P > 0.01, between band c: 0.025 >P > 
0.02, between d and e: 0.05 >P >o.025, e and f: 0.05 >P >o.025. 
Not significantly different are a and b nord and f. 
immuno-reactive enzyme protein gradually increases in the blood. In these 
experiments we determined the amount of antiserum required to inhibit 50% 
of the liver enzyme activity, as described in Table IV. 
Influence of fat feeding on liver lipase activity in postheparin serum 
Rats were fed a rapeseed oil-rich or an olive oil-rich diet for 10 days. The rats 
were fasted for 24 h and subsequently injected intravenously with 10 I.U. 
heparin per 100 g bodyweight. 6 min later blood was withdrawn to prepare the 
postheparin serum in which lipolytic activity was assayed. Table V shows that 
in accordance with earlier observations [11] the total lipase activity in the 
postheparin serum of the rapeseed oil-fed rats is higher than that of the olive 
oil-fed rats or of the control rats. From the second and third columns of this 
table it appears that this elevation is mainly due to increased liver enzyme 
activity and that the total contribution of the extrahepatic organs to serum 
palmitoyl-CoA hydrolase activity remains fairly constant. It is known that the 
state of nutrition may influence the heparin-releasable lipase activity. The same 
experiment was therefore repeated without fasting the rats before the injection 
of heparin. The results are shown in Table VI. Clearly the activities of the liver 
TABLE VI 
CONTRIBUTIONS OF LIVER AND EXTRAHEPATIC ORGANS TO THE HYDROLASE ACTIVITY 
OF POSTHEPARIN SERUM OF RATS FED ON VARIOUS DIETS 
Conditions as in Table IV, but without fasting before the heparin-injection. 
Diet 
Laboratory chow 
Olive oil 
Rapeseed oil 
Number 
of rats 
2 
4 
4 
Hydrolase activity in the serum 
Total Hepatic 
224 ± 20 172±1oa 
268 ± 22 229 ± 15b 
286 ± 12 235 ± 9' 
Statistically different is a from b or c (0.01 >P 0.005). 
Extrahepatic 
52 10 
39 7 
51 3 
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TABLE VII 
''SPECIFIC ACTIVITIES" OF THE LIVER HYDROLASE ACTIVITY IN POSTHEPARIN SERUM OF 
RAPESEED OIL AND OLIVE OIL-FED RATS 
The amount of postheparin serum, in which hydrolase activitY was inhibited by a fixed amount of anti· 
serum ("specific activity"), was estimated as described under Methods. The same sera were used as in 
Table V. The activitY inhibited by the fixed amount of antiserum was calculated and expressed in munits 
(nmoles Co ASH liberated/min). Palmitoyl-CoA was the substrate. 
Diet 
Rapeseed oil 
Olive oil 
Liver hydrolase activity inhibited by a fixed amount of antiserum (munits) 
Exptl 
1.97 
1.31 
Expt II 
1.94 
1.32 
enzymes from rapeseed oil- or olive oil-fed rats are equal, but significantly 
higher than from rats fed with a normal laboratory chow diet. 
In order to obtain some insight in the mechanism of the activation of the 
liver enzyme we estimated whether the higher activity of the liver lipase in the 
rapeseed oil-fed rats (Table V) was due to more enzyme or to a more active 
enzyme. Table VII demonstrates that the same quantity of antiserum binds 
more activity in the rapeseed oil-fed rats than in the olive oil-fed rats. From this 
it could be concluded that the elevation of activity in the rapeseed oil-fed rats 
is due to a more active enzyme. Both Tables V and VI suggest that feeding rats 
with an olive oil-rich diet results in low extra hepatic palmitoyl-CoA hydrolase 
activity. That this could possibly reflect a low (extra-hepatic) lipoprotein lipase 
activity is suggested in experiments presented elsewhere [18], in which olive 
oil-rich feeding also results in low cardiac triacylglycerol hydrolysing activity. 
Discussion 
In this paper it is shown that the relative contribution of liver and extra-
hepatic organs to the postheparin lipase activity of serum strongly depends on 
the dosis of heparin injected (Table II) and the time of removal of blood from 
the animal (Table III). Whereas the extrahepatic organs may remove triacylgly-
cerols from the serum [6,7], for which their lipoprotein lipase activity at the 
capillary lining may be essential, the liver is thought mainly to contribute to 
the formation of serum triacylglycerols (as very-low-density lipoproteins) and 
not to their utilization. Yet the liver, especially when high concentrations of 
heparin are injected, contributes to a large extent to the serum lipase activity 
(ref. 4 and Tables II-IV of the present paper). Probably then the high liver 
activity against triacylglycerols does not represent the capacity of the liver to 
hydrolyse these substrates in vivo. It should be noted that the high liver activ-
ities are measured when high doses of heparin are injected. These high doses are 
highly unphysiologically. Condon et al. [19] found that after hepatectomy of 
dogs the release of lipolytic activity by heparin into the serum was somewhat 
retarded, when compared to control dogs. That the same may hold for rats can 
be seen from Tables III and IV. We found that the hepatic contribution is 
removed from the serum more rapidly after heparin injection than the extra-
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hepatic contribution. The liver enzyme is completely removed from the serum 
and not inactivated while still being in the serum (Table IV). What happens to 
the lipase activity when removed from the circulation is not clear. Whether the 
activity remains operative or is inactivated has to be investigated. The place 
where the lipase is removed from the serum is not known although evidence has 
been brought forward that it may be the liver [21,22]. 
From the data shown in Table V it can be seen that fat feeding enhances 
the heparin-releasable lipase activity of hepatic origin in postheparin serum. 
The activity of extrahepatic origin is slightly lowered by olive oil feeding and 
significantly after fasting (Tables V and VI). This may be of considerable 
importance since lipoprotein lipase activity may be involved in atherogenesis 
(Zilversmit [23], Hiilsmann and Jansen [24]) and hence deserves more 
documentation. In contrast to the lipase activity of the rat heart (ref. 18) the 
elevation of the liver lipase activity is independent whether erucic acid 
(C22 : 1; a major component of rapeseed oil) is the major acid or not (Table 
VI). In the fasted state, however (Table V), the liver lipase of the rapeseed 
oil-fed rats remains at a higher level than that of the olive oil- or chow-fed rats. 
Whether the difference in liver lipase activity in the fasted state must be at-
tributed to a direct effect of different fatty acids or to a secondary effect 
cannot be concluded yet. A possible explanation may be that after rapeseed oil 
feeding, due to the prolonged alimentary lipemia after rapeseed oil digestion 
[26], the animals are in a less fasted state than other animals. Of interest is the 
observation that the higher activity of the liver enzyme is not due to more 
enzyme but to a more active enzyme (Table VII). The factor that determines 
the activity of the liver is unknown. One possibility is that the enzyme is 
normally present in both active and inactive forms and that the equilibrium is 
shifted to the more active state in the (rapeseed) oil-fed rats. Another simple 
explanation may be the stabilization of the enzyme by triacylglycerols. The 
role of the liver lipase activity in the overall triacylglycerol metabolism remains 
uncertain, but may be involved in the degradation of low- and high-density 
lipoproteins (compare Introduction). 
From the presented data (Tables III and IV) it is concluded that the 
palmitoyl-CoA hydrolase activity in postheparin serum is mainly of hepatic 
origin, a conclusion already reached earlier by us [ 4]. This illustrates the differ-
ent substrate specificities of the various postheparin serum hydrolases (compare 
also ref. 25). Whether the lipolytic activities released from the liver by heparin 
perfusion are due to the release of one enzyme or due to the release of phos-
pholipase [8,10,20], monoacylglycerol lipase [9], palmitoyl-CoA hydrolase 
and triacylglycerol lipase as separate enzymes, with perhaps overlapping sub-
strate specificity, requires further investigation. The choice of substrate by the 
in vitro estimation may influence the relative contributions of liver and extra-
hepatic enzymes considerably. Therefore, no direct conclusions of the in vivo 
capability of different organs in the hydrolysis of endogenous substrates may 
be drawn from the activities measured in postheparin serum in vitro. From this 
paper it becomes clear that the amount of heparin and the time of blood 
removal may influence the activities in postheparin serum. 
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SUMMARY 
The present paper shows that the palrnitoyl-CoA hydrolase 
activity of postheparin serum of the rat is mainly derived 
from the liver. The identity of this activity with the 
heparin-releasable hepatic triacylglycerol hydrolase acti-
vity is established. The consequence of the different sub-
strate specificities of the hepatic and extrahepatic enzy-
mes for the measurement of the overall postheparin serum 
lipase activity are discuss_ed. 
Treatment of the rats with either a corticosteroid or 
with streptozotocin was found to lower the lipolytic acti-
vity from the liver and to enhance the extrahepatic acti-
vity. 
Also in human postheparin serum palmitoyl-CoA hydrolase 
activity is shown to behave identical with hepatic triacyl-
glycerol hydrolase activity'. 
The possible function of the liver in the serum triglyce-
ride metabolism is discussed in connection with the pro-
posed mechanism for the role of extrahepatic lipoprotein 
lipase in atherogenesis. 
INTRODUCTION 
Lipolytic activity of postheparin serum originates from 
different organs. The enzymes of hepatic and extrahepatic 
origin differ in substrate specificity1 , sensitivity to 
l 
various inhibitors2 and are immunologically distinguish-
3-5 
able . The liver may contribute up to 60% of the total 
triacylglycerol hydrolase activity of postheparin serum of 
the rat5 . Also in man a large part of the serum triacylgly-
cerol hydrolase activity is derived from the liver 214 P but 
like in the rat the contribution is very dependent on the 
time of blood removal after the heparin injection416 The 
extrahepatic enzyme(s) hydrolyze(s) the triacylglycerol 
moiety of chylomicrons and very low density lipoproteins 
The liver may play a role in the breakdown of remnant par-
·ticles of very low density lipoproteins and chylomicrons 7 
The role of the heparin-releasable liver lipase activity is 
not yet established, though recent investigations of MUller 
et a1. 8 point to a key-role for this activity in the break-
down of the lipid moiety of these particles. In a previous 
9 paper we showed that postheparin serum also hydrolyzes 
palrnitoyl-CoA. We now present experiments to show that the 
liver preferentially hydrolyzes palmitoyl-CoA. Since the 
breakdown of palmitoyl-CoA can be easily followed spectro-
photometrically, the estimation of palmitoyl-CoA hydrolase 
activity offers a simple method for the determination of 
the heparin-releasable liver enzyme. Furtheron the effects 
of cortisol and streptozotocin treatment on the lipase 
activities of rat serum are reported. 
~IATERIALS AND HETHODS 
Hale Wistar rats of 220 .:!: 20 g were used in all experi-
ments, unless stated otherwise. Heparin (100 I.U./mg) was 
from Organon, Oss, the Netherlands; streptozotocin was a 
gift from the Upjohn Company, Kalamazoo, U.S.A.; Kenacort 
(triarncinolonacetonide, 40 mg/ml) was from Squibb and 
Sons; [2-3H] glyceroltrioleate was from the Radio Chemical 
Center, Amersham, Great Britain. Palrnitoyl-CoA was made as 
described before 9 . 
1-Monoacylglycerol hydrolase activity was estimated as 
follows. The [2- 3H] glycerolrnonooleate was separated by 
2 
thinlayer chromatography on silicagel from the [2-3H] gly-
ceroltrioleate. About 2.5 ~Ci of the [2- 3H] rnonoacylglyce-
rols were mixed with 68 mg glycerolmonooleate, 8.1 mg leci-
thin, 1.5 ml 10% fat-free albumin (pH 8.0), 0.8 ml Tris-
HCl buffer (2 I-I, pH 8. 2) and water was added to make 3. 0 
ml. After sanification of this mixture with a Branson soni-
fier (4 times 1 min with intermittent cooling), the mixture 
was incubated during 30 min at 37°C "'ith 6 ml preheparin 
human serum (citrate plasma clotted by addition of ca2+ 
and dialysed). Then the reaction was started by addition 
of 25 ~1 postheparin serum to 0.975 rnl of the described 
substrate. After 30 min the reaction was stopped with 1 ml 
10% trichloroacetic acid and glycerol estimated according 
to Schatz and Garfinke1 10 . In a series of experiments the 
glycerol liberated was also estimated enzymatically, ahvays 
with the same results as obtained in the radioactive assay. 
Triacylglycerol hydrolase activities in postheparin sera 
were estimated as described before (ref. 9) with "Intra-
lipid" {10%) as the substrate, with one slight modification 
in that from the reaction mixture no longer samples were 
taken at 15, 30 and 45 min, but the reaction was now 
carried out in triplicate and samples were taken after 30 
min. Glucose was estiwated as described by \"lerner et a1. 11 , 
insulin "'as determined Vli th a slightly modified method of 
Yalow and Berson12 . 
RESULTS 
Stability of palmitoyl-CoA hydrolase activity and triacyl-
glycerol hydrolase activity during incubation at different 
E!!. 
In earlier experiments 3 "'e found that palrnitoyl-CoA 
hydrolase activity is rather stable during incubation of 
postheparin rat serum for 30 min at 37°c. During preincu-
bation v1i th rabbit serum, hov1ever, inactivation of the 
triacylglycerol hydrolase activity occurred. We found that 
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Fig. 1. Inactivation of postheparin serum hydrolase activi-
ties during preincubation at different pH. 0.9 rnl posthepa-
rin serum was incubated with 0.1 ml 1 H Tris-HCl buffer 
with varying pH. The incubation was for 30 min at 37°C. 
After the incubation palrnitoyl-CoA hydrolase activity and 
triacylglycerol hydrolase activity (expressed as nrnoles 
F.F.A./min/rnl) were estimated (at pH 8.5), as described 
under HETHODS. The bars represent the activities obtained 
(after the preincubation) expressed as the % of the activi-
ties measured without preincubation. The triacylglycerol 
hydrolase activities and the palmitoyl-CoA hydrolase acti-
vities are represented by the black part and the total 
height of the bars respectively. 
the pH could influence the stability of the palrnitoyl-CoA 
hydrolase activity. Therefore, the inactivation of the 
palrnitoyl-CoA hydrolase activity and of the triacylglyce-
rol hydrolase during preincubation at 37°C for 30 min at 
different pH's was followed (fig. 1). The triacylglycerol 
hydrolase activity when measured ~lithout preincubation was 
353 mU/ml. The palrnitoyl-CoA hydrolase activity was 251 
mU/rnl. From this figure it is seen that the palmitoyl-CoA 
4 
hydrolase activity is stable at a pH between 7.0 and 7.3, 
but that the triacylglycerol hydrolase activity is partly 
inactivated by the preincubation at 37°c. With increasing 
pH's both activities became progressively inactivated . 
Postheparin serum palmitoyl-CoA hydrolase activity: origin 
and purificati~n by affinity chromatography 
In a previous paper5 we showed with the help of an anti-
body against liver lipase activity that about 80% of the 
postheparin palmitoyl-CoA hydrolase activity is derived 
from the liver. This is now confirmed by experiments with 
hepatectomized rats (TABLE I). From this TABLE it can be 
seen that the palmitoyl-CoA hydrolase activity in the serum 
of hepatectomized rats is only 22% of the activity found in 
intact rats. This confirms the earlier published observa-
tions5. 
TABLE I 
RELEASE OF PAU.IITOYL-CoA HYDROLASE ACTIVITY BY HEPARIN IN 
INTACT AND HEPATECTOHIZED RATS 
4 rats were hepatectomized in a two stage procedure under 
ether narcosis. In the first stage 65-75% of the liver 
was removed according to Higgins and Anderson 13 • Subse-
quently a porta cava shunt was made as described by Fisher 
and Lee14 • After the operation the rats were allowed to 
recover for 30 min. Then 50 I. U. heparin 'tllere injected and 
blood was withdrawn 2 min later. Four intact rats served 
as controls. In the sera palmitoyl-CoA hydrolase activity 
was estimated as described before 9 • 
Rats 
Controls (n=4) 
Hepatectomized (n=4) 
Palmitoyl-CoA hydrolase 
(nmoles CoASH liberated/min/rnl serum 
+ S.D.) 
217 + 15 
49 + 18 
5 
From the liver different lipolytic activities are re-
b h . 1,15 leased y epar1n . Human, postheparin serum triacyl-
glycerol hydrolase activity of hepatic origin is eluted by 
about 0.7 NaCl from a Sepharose-heparin column 16 . Lipase 
activities of rat heart and rat adipose tissue are eluted 
at a higher salt concentration (1.2 M NaC1) 17 . Ehnholm et 
a1. 18 found two activity peaks after the elution of human 
postheparin serum lipases from a Sepharose-heparin column 
with a salt gradient. The activity eluted at 0.7 M NaCl 
had the characteristics of the li~er enzyme and the activi-
ty eluted at 1.2 M NaCl the characteristics of the extrahe-
patic lipoprotein lipase. We now investigated, whether the 
palmitoyl-CoA hydrolase activity released from the liver 
(see TABLE I) could be separated from the liver triacyl-
glycerol hydrolase activity by elution from a Sepharose-
heparin column (Fig. 2}. From this figure it is concluded 
that about 90% of the palmitoyl-CoA hydrolase activity is 
eluted in the same activity peak as the liver triacylgly-
cerol hydrolase activity by 0.7 M NaCl (comp. refs. 16 and 
18}. The recovery of the palmitoyl-CoA hydrolase activity 
was 81%. Furthermore it can be seen that in the activity 
peak eluted by 0.7 NaCl the breakdown of triacylglycerol 
to free fatty acids and glycerol is complete (molar ratio 
of 3 to 1). In the activity peak eluted by 1.2 M NaCl the 
release of acylglycerol to free fatty acids greatly exceeds 
the release of glycerol (molar ratio 8.5 to 1}. This is in 
accordance with the findings of Krauss et a1. 20 , with en-
zymes obtained by perfusion of liver and extrahepatic 
tissues. The recovery of triacylglycerol hydrolase activity 
when estimated by the fatty acids released from triacylgly-
cerol was 80%. The recovery of triacylglycerol hydrolase 
activity when estimated as glycerol released from triacyl-
glycerol was only 49%. This can be explained by the incom-
plete breakdown of the triacylglycerol in the 1.2 M NaCl 
peak. In the postheparin serum applied to the column the 
liver enzyme will be able to hydrolyze part of the partial 
6 
acylglycerols formed by the extrahepatic enzyme (see also 
DISCUSSION). The liver enzyme releases from palmitoyl-CoA 
about 1.7 times more nmoles CoASH per min than nmoles free 
fatty acids from triacylglycerol. The extrahepatic enzyme 
releases about 8 times more free fatty acids from trioleate 
than nmoles CoASH from palmitoyl-CoA. This ratio can be 
slightly overestimated however, because of the incomplete 
recovery for the palmitoyl-CoA hydrolase activity. The 80% 
recovery for the activity measured as free fatty acids re-
leased can be ascribed to a low rate of hydrolysis of par-
tial acylglycerols formed by the extrahepatic enzyme as 
outlined above. 
In vitro breakdown of triacylglycerol to free fatty acids 
and glycerol by postheparin serum, collected after the in-
jection of different amounts of heparin 
It is tentatively concluded from the experiments shown 
above {Fig. 2) that, when measuring glycerol release from 
triacylglycerol by postheparin serum, the liver enzyme can 
be the rate-limiting step. TABLE II shows that the ratio 
of released fatty acids over released glycerol by posthe-
parin serum from a triacylglycerol substrate, depends on 
the amount of injected heparin. The stimulation of Intra-
lipid hydrolyzing activity by increasing the amount of 
heparin used, amounts to 255 nmoles fatty acids and 74 
nmoles glycerol released per min per ml serum, approxima-
ting a fatty acid to glycerol ratio of 3. This suggests 
that predominantly the liver enzyme is released by the 
higher heparin dose, in accordance with earlier observa-
tions4'5. The 1-rnonoacylglycerol hydrolase activity is 
less activated by the higher heparin dose than the other 
measured activities. \.~hen the liver enzyme is precipitated 
with a specific antibody, the molar ratio of released 
fatty acids to released glycerol in the remaining activity 
is again 8 to 1 (see data between brackets in TABLE II) as 
may be expected for the extrahepatic enzyme. 
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Fig. 2. Elution of hydrolytic activities of postheparin 
serum from a Sepharose-heparin column by NaCl. 60 rnl post-
heparin serum of rats injected with 50 I.U. heparin was 
applied to a Sepharose-heparin column (0.9 x 10 em}. After 
passage of the serum over the column, the column was washed 
with 50 mM Tris-HCl buffer pH 7.2 until no more protein was 
eluted. Then a linear NaCl gradient was applied to the 
column of 0 to 2 M NaCl in the Tris buffer (60 rnl). Frac-
tions of 2 ml were collected. Within 2 hrs the fractions 
were tested for palrnitoyl-CoA hydrolase activity and for 
triacylglycerol lipase activity. In the palmitoyl-CoA assay 
10 ~1 preheparin serum per rnl reaction medium was present. 
\\Then "Intralipid" was the substrate, the reaction was 
followed in two wa¥s· The substrate was fortified with 
glycerol tri[l- 14 CJ oleate and [2- 3 H] glycerol labeled gly-
ceroltrioleate. After preincubation with preheparin serum 
just as described in ref. 9, 2.70 ml substrate was incuba-
ted with 0.15 ml of the column fractions for 30 min at 37°C. 
After the incubation the released [2-'H] gl¥cerol was esti-
mated as described by Schatz and Garfinkel 1 • The released 
free fatty acids were estimated in another ml of the reac-
tion mixture as described in ref. 9. (1-1) represents 
nmoles CoASH released from palmitoyl-CoA/min/ml eluate, 
(A-A) nrnoles free fatty acids from trioleate/rnin/rnl and 
(1-1) nmoles glycerol from trioleate/rnin/rnl. 
8 
"' 
TABLE II 
HYDROLYTIC ACTIVITIES OF POSTHEPARIN SERUM AFTER THE INJECTION OF DIFFERENT AMOUNTS OF 
HEPARIN 
Male Wistar rats (290 + 10 g) were injected with 2 or 50 I.U. of heparin. After 6 min they 
were killed and their blood \>las withdrawn. In the sera the release of free fatty acids and 
glycerol from "Intralipidn was measured as described in the legends to Fig. 2. Also the 
1-monoacylglycerol hydrolase activity and the palmitoyl-CoA hydrolase activity were esti-
mated, as described under METHODS. Between brackets the activities are given, after pre-
incubation of the sera with an antiserum against the liver lipase exactly as described in 
ref. 5. Activities are given~ standard deviations. 
Amount of heparin 
injected (I. U.) 
2 (n=3) 
50 (n=3) 
Hydrolytic activity measured with the substrate 
"Int::.ralipid 11 
nmoles F .F .A.) nmoles glycerol/ 
rnin/ml min/ml 
125 + 15 20 + 2 
380 + 40 94 + 2 
(163 + 15) (21 :>_ 3) 
I-mot160leate 
nrnoles 91Ycerol/ 
min/ml 
180 + 10 
304 + 10 
PalrnTEOyl-CoA 
nmoles CoASH/ 
rnin/rnl 
58 + 4 
220 + 9 
Effect of experimental hypercortisolism and diabetes on 
the heparin-releasable lipase activities 
Earlier we found 5 that fasting lowers the postheparin 
palmitoyl-CoA hydrolase activity. In order to study 
whether the insulin of the blood could affect the liver 
lipase activity and to study whether the hypertriglyceri-
demia in diabetes (see also ref. 26) could be explained 
by altered serum lipase activities, we made rats diabetic 
with "streptozotocin 11 (TABLE III). From this TABLE it is 
seen that in the diabetic rats the palmitoyl-CoA hydrolase 
activity is lowered, but that the total triacylglycerol 
hydrolase activity in the postheparin serum is significant-
ly elevated. The release of glycerol from triacylglycerol 
is constant. In experiments with rats made diabetic with 
alloxan (180 rng/kg body weight) the palmitoyl-CoA hydrolase 
activity was even lo\ITer (30 mU/ml). These experiments were 
however not further extended because of the high mortality 
rate of the rats by the treatment. 
In TABLE IV it can be seen that the administration of a 
corticosteroid also influences the liver- and total lipo-
lytic activities of postheparin serum. The possible impli-
cations of this finding are pointed out in the DISCUSSION. 
Palmitoyl-CoA hydrolase activity in human postheparin serum 
Also in humans palmitoyl-CoA hydrolase activity is re-
leased by heparin9 . We found that, as with rat serum (Fig. 
2) ' 
0.7 
the palmitoyl-CoA hydrolase activity was eluted by 
M NaCl from a 
Fig. 3 it is seen 
Sepharose-heparin column (not shown) , In 
that in man palmitoyl-CoA hydrolase acti-
vity reaches a maximum within 5 min after the injection of 
heparin. The total lipase activity reaches a maximum after 
about 40 min. From very recent work of Krauss et a1. 6 it 
appears that also the liver triacylglycerol hydrolase ac-
tivity is maximal shortly after the heparin injection. 
Therefore in man the palmitoyl-CoA hydrolase activity seems 
to correlate also with the liver triacylglycerol hydrolase 
activity. 
10 
.... 
.... 
TABLE III 
POSTHEPARIN SERUM LIPASE ACTIVITIES IN EXPERIMENTAL DIABETES 
Rats (290 + 10 g) were injected in the tailvein with 40 mg streptozotocin/kg body weight. 
After 7 daYs 50 I.U. heparin were injected and after 6 min their blood was collected. In 
the serum glucose and insulin were estimated. Rats with a bloodglucose level >300 mg/100 
ml were selected as being diabetic. In their sera palmitoyl-Con hydrolase and triacylgly-
cerol hydrolase activities were estimated. The same rats of TABLE II served as controls. 
Activities are given + standard deviations. 
Treatment 
None (n~3) 
Streptozotocin (n=4) 
Triacylglycerol hydrolase 
nrnoles F.F.A./miri]IDl nmoles glycerol/min/ffil 
380 + 40a 
551 + 2lb 
94 + 2c 
98 + 7d 
Palmitoyl-CoA hydrolase 
nrnoles CoASH/min/ml 
220 + ge 
131 + lOf 
Statistically different are a from b and e from f: P<O.OOS; not significantly different 
is c from d . 
~ 
N 
TABLE IV 
INFLUENCE OF FEEDING, FASTING AND EXPERIHENTAL HYPERCORTISOLISH ON LIPASE ACTIVITIES OF 
POSTHEPARIN SERUH OF RATS 
One group of rats was normally fed \·lith laboratory chow. From another group the food was 
withdrawn at l6.oo p.m. when they were used the next day. The third group was injected 
intramuscularly vlith 4 mg Kenacort. After 48 h their food was withdrav1n and the rats used 
after 18 h as in the fasted group. 50 I. U. heparin was injected and blood \rli thdrawn 6 min 
later. Glycerol release and fatty acid release from "Intralipid" was determined as des-
cribed elsewhere in this paper. Palmitoyl-CoA hydrolase activity was estimated as described 
in ref. 8. l-!'-1onoacylglycerol hydrolase was estimated in two rats of the fed and "Kenacort" 
treated group as described under METHODS. I.R.I. signifies immunoreactive insulin .. hctivi-
ties are given+ standard deviations. 
Condition of 
the rats 
Normally fed 
Fasted 
"Kenacort" 
treated 
Triacylglycerol hydrolase 
(nr':l.oles fatty (nmoles glycerol/ 
acids/min/ml) min/ml) 
(n~3) 324 + 40a 82 + 3d 
(n~3) 241 + llb 
(n~3) 498 + 92c 71 + lOe 
1-Monoacylglyce-
rol hydrolase 
(ilffioles glycerol/ 
rnin/rnl) 
225 + 30f 
450 + sg 
Palmitoyl-CoA 
hydrolase 
(nmoles -CoASH/ 
rnin/rnl) 
190 + 6h 
133 + l7j 
99 :': l7k 
I .R.I. 
~U/mT 
130 
51 
225 
Statistically different are a from b and c: O.OS>P>0.025; b from c, and f from g, and h 
from k: P<O.OOS; h from j: O.Ol>P>O.OOS and j from k: O,l>P>O,OS; not significantly dif-
ferent is d from e. 
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Fig. 3. Palmitoyl-CoA hydrolase and triacylglycerol hydro-
lase activities after intravenous heparin injection in man. 
100 I.U. heparin/kg body weight was injected in a 30 year 
old volunteer. Blood was withdrawn at different times 
after the heparin injection. In the sera palrnitoyl-CoA 
hydrolase activity and triacylglycerol hydrolase activity 
were determined. 
DISCUSSION 
19 In accordance with the results of Bensadoun et al. , 
with lipoprotein lipase from pig adipose tissue, we found 
that the extrahepatic lipoprotein lipase was inactivated 
faster at a higher pH. The heparin-releasable liver enzyme 
was found to be stable at a pH between 7.0 and 7.3, but 
became progressively inactivated with increasing pH (Fig. 
l) • 
Fig. 2 shows that the liver enzyme hydrolyzes triacylgly-
cerol completely to free fatty acids and glycerol. The 
extrahepatic enzyme(s) release(s) free fatty acids and gly-
cerol in a molar ratio of about 8 to 1, which is in accor-
dance with earlier observations of Krauss et al. 
It was shown that the liver releases about 80% of the 
total palmitoyl-CoA hydrolase activity of postheparin serum 
(TABLE I). Palmitoyl-CoA hydrolase activity shares many 
characteristics with heparin-releasable triacylglycerol 
lipase: a) identical sensitivity towards an antibody pre-
paration5, b) identical elution patterns of both activities 
from a Sepharose-heparin column (Fig. 2}, c) agreement be-
tween our results with palmitoyl-CoA (Fig. 3) and those of 
Krauss et a1. 20 with triacylglycerol as substrate for the 
liver enzyme. Therefore the conclusion that liver triacyl-
glycerol hydrolase and palmitoyl-CoA hydrolase activities 
are catalyzed by the same protein seems to be justified. 
Additional support is given in TABLE II, where it is shown 
that by the injection of different amounts of heparin a 
different ratio of in vitro released free fatty acids to 
released glycerol from triacylglycerol by the postheparin 
sera is found. This ratio is higher at low heparin concen-
trations (low hepatic enzyme activity) and increases when 
more heparin is injected. The 1-monoacylglycerol hydrolase 
activity behaves different. That the 1-rnonoacylglycerol 
hydrolase activity is catalyzed by another enzyme was in 
fact already shown by Nilsson-Ehle21 who found that post-
heparin triacylglycerol hydrolase(s) and 1-monoacylglycerol 
hydrolase activities of human serum could be separated. 
Recent work of PykalistO et al. 22 shows a correlation 
between the phospholipase of liver and 1-monoacylglycerol 
hydrolase. Waite and Sisson found that 1-monoacylglycerol 
but not 2-rnonoacylglycerol or triacylglycerol can act as 
acyl donor in reactions catalyzed by rat liver phospho-
lipase23. Also in TABLE IV it is shown that the 1-monoacyl-
glycerol hydrolase activity is affected differently from 
the liver palmitoyl-CoA hydrolase activity by cortisol 
treatment. 
During the hydrolysis of triacylglycerol by extrahepatic 
lipoprotein lipase partial glycerides are formed. These 
14 
partial glycerides can be hydrolyzed by the hepatic enzyme. 
In this way the activity of the extrahepatic lipoprotein 
lipase can influence the in vitro measured activity of the 
liver enzyme, particularly when the extrahepatic lipopro-
tein lipase produces a considerable amount of partial gly-
cerides. Such a mutual interaction of liver and extrahepa-
tic activities does not occur when palmitoyl-CoA is used 
as the substrate. The liver enzyme hydrolyzes palmitoyl-
CoA much faster than the extrahepatic lipase (Fig. 2). 
Therefore we think that measurement of palmitoyl-CoA hydro-
lase activity in addition to triacylglycerol lipase activi-
ties of postheparin serum may be of use in the study of 
serum lipases. In TABLES III and IV it can be seen that 
such a simultaneous estimation of palrnitoyl-CoA hydrolase 
and of triacylglycerol hydrolase activities provides in-
formation about the relative contributions of hepatic and 
extrahepatic lipase activities. 
In view of the above mentioned reasons it is worthwhile 
considering that Orosz et a1. 24 and Jaillard et a1. 25 mea-
sured glycerol release by postheparin serum of normal and 
atherosclerotic subjects. Since the time course of enzyme 
activity release after heparin injection as found by Orosz 
et a1. 24 is the same as for the liver lipase (Fig. 3 and 
ref. 6), it might be suggested that probably the lipolytic 
activity decrease in atherosclerotic persons stands for a 
decrease of liver activity. Mliller et a1. 8 found secondary 
to liver disease lowered hepatic lipolytic activity and 
hypertriglyceridernia, due to an elevated remnant particle 
concentration. Also in diabetes the hypertriglyceridemia 
may have resulted from an elevated remnant particle concen-
tration. According to Schonfeld et a1. 26 accumulation of 
these particles causes hypertriglyceridemia in diabetes. 
In the present paper we show that in diabetic rats the 
liver lipase activity is significantly lowered. The hyper-
triglyceridemia in these rats cannot be explained by a 
lowered extrahepatic lipoprotein lipase (TABLE III), nor by 
15 
an increased triglyceride production27 Boberg28 found the 
best inverse correlation of enhanced serum triglyceride 
content and 5 min postheparin lipase activity in man. From 
Fig. 3 and ref. 6 it is seen that under these circumstances 
the liver activity has a maximal contribution, again sug-
gesting the important role that the liver enzyme may play 
in the removal of serum triglycerides. Putting these facts 
together, it is clear that the determination of liver and 
extrahepatic lipolytic activities, which can be done by 
determination of the ratio of palmitoyl-CoA hydrolase and 
triacylglycerol hydrolase activities in postheparin serum, 
may be an important step in the elucidation of serum tri-
glyceride transport. Remnant particles of very low density 
lipoproteins may be involved in atherogenesis 29 . The 
possible role of the liver enzyme in the breakdown of these 
particles suggests the contribution of a lo~t;ered liver lipo-
lytic activity in addition to an enhanced (heart-) muscle 
lipoprotein lipase 30 , 31 activity in the etiology of athero-
sclerosis. Results of Orosz et a1. 24 and Jaillard et a1. 25 
seem to be in line with this hypothesis. 
Lipoprotein lipase activities of heart and/or adipose 
32 tissue are possibly regulated by the serum glucagon and 
insulin33 , 34 levels. For the liver lipase no direct effect 
of the insulin level of the blood could be demonstrated 
(TABLES III and IV) . 
It is knovm, hov;ever 1 that hypercortisolism leads to an 
enhanced glucagon production and insulin resistence. There-
fore the effective glucagon/insulin ratio in this hormonal 
state may be enhanced like in diabetic rats (TABLE III) . 
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INFLUENCE OF RAPESEED OIL FEEDING ON THE LIPASE 
ACTIVITIES OF RAT HEART 
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SUMMARY. Feeding high doses of fat increases the lipase activity 
of rat heart. The heparin-releasable activity in the hearts of rape-
seed oil fed rats remains high after prolonged feeding (10 days)~ 
whereas this activity in olive oii fed rats returns to normal values 
in the same period. After 10 days rapeseed oil feeding the non-
releasable lipase activity in the hearts is enhanced significantly, 
when compared to the activity measured after 3 days. The results 
suggest an adaptation of heart 1ipases to dietary fat. 
Triglycerides accumulate in the hearts of rats fed a high 
erucic-acid containing rapeseed oil diet1 . The fat content of the 
hearts is highest after 3 to 6 days feeding and is rapidly lowered 
after 6 days 2 . The fat accumulation in the hearts has been ascribed 
to the inhibition of the S-oxidation by erucic acid3 and by a lower 
4 
rate of the overall metabolism of erucic acid in the heart . Gumpen 
and Norurn5 suggested that the fat accumulation might arise from an 
impaired input/output of free fatty acids by the hearts. Rat hearts 
can take up free fatty acids from the serum directly. Serumtriglyce-
rides can be taken up after previous hydrolysis by heart lipoprotein 
lipase, in which the heparin-releasable part of this enzyme activity 
is involved6 • An impaired input/output of free fatty acids in the 
hearts could, therefore, be related with changes in the lipoprotein 
lipase activity of the hearts during rapeseed oil feeding. The 
heparin-releasable and non-releasable lipase activities of rat hearts 
were estimated selectively by in vitro heart perfusions. Control 
hearts were obtained from rats fed a diet containing high levels of 
olive oil. Olive oil does not introduce gross fat accumulation in 
heart. 
1 
TABLE I 
LIPASE ACTIVITIES OF RAT HEART AFTER THE FEEDING OF DIFFERENT DIETS 
DURING 3 DAYS. 
Rats were fed various diets for 3 days as described under METHODS. 
Then their hearts were perfused in vitro and lipase activities 
were estimated in the perfusates and in acetone powders of the 
perfused hearts. The activities are expressed in nmoles of free fatty 
acid released per min per heart + standard deviation. 
Diet Li2ase activit:z: in Total 1 i pa se 
perfusates the hearts after activity per 
perfusion heart 
Rapeseed oi 1 ( n= 5) 253 + 1 01 374 ~ 15 0 627 
011 ve oi I ( n= 5) 294 ~ 67 343 + 124 637 
Laboratory chow (n=3) 83 + 32 202 ~ 30 285 
TABLE I I 
LIPASE ACTIVITIES OF RAT HEART AFTER FEEDING DIFFERENT DIETS DURING 
10 DAYS. 
Two groups of 6 rats were fed a rapeseed oil-rich or an olive oil-
rich diet for 10 days. Then their hearts were perfused. The 
perfusates of 3 rats of each group were pooled and lipase activities 
were estimated. The same was done with acetone-powders of the hearts. 
The activities are expressed in nmoles of free fatty acid released 
per min per heart + standard deviation. 
Diet 
perfusates 
Rapeseed oi 1 296 ~ 28 
01 i ve oll 120 + 7 
2 
the hearts 
perfusion 
5D4 ~ 64 
324 ~ 16 
after 
Total lipase 
activity per 
heart 
800 
444 
METHODS. Groups of male Wistar rats, weighing 250 to 300 g, were 
given for 3 or 10 days fat-rich diets consisting of 50 cal% rape-
seed oil (48% C 22:1 n-9) or 50 cal% olive oil (78% C 18:1 n-9) 
and further 27 cal% carbohydrate (maize starch), 23 cal% casein, 
different salts and vitamins. The rats had constant access to 
water and food. 
Lipase activity was measured b8 the method of Kelley?, which 
was modified as described elsewhere . Rat hearts were perfused 
according to the Langendorff technique with a modified Tyrode 
solution at a pressure of 100 em HzO and at 33 + 3°C. After 5 min 
the perfusion medium was replaced by one containing, in addition, 
20% (v/v) rat serum and 4.5 I .U. heparin/ml (Organon, Oss, The 
Netherlands). The hearts were perfused with 50 ml of the latter 
medium. The 1 ipase activities of the perfusates, which were cooled 
to ooc immediately after collection, were estimated within 4 h. 
The lipoprotein lipase activity of the heart tissues was deter-
mined in total acetone powder homogenates9. 
RESULTS 
The average weights of the hearts of the rats were 1.04 + 0.10 
g for the rapeseed oil fed rats, 0.98 ~ 0.08 g for the olive oil 
fed rats and 0.90 ± 0.04 g for the rats fed laboratory chow. 
TABLE I shows the heparin-releasable lipase activities as well 
as the residual activities in the hearts of rats fed various 
diets. It can be seen from this TABLE that both activities are 
elevated in the rats fed a diet with a high fat content when com-
pared to rats fed the normal laboratory chow. The variation in the 
measured activities is large as can be seen from the standard 
deviations. The total lipase activity in the hearts of the groups 
fed olive oil or rapeseed oil is not significantly different. After 
10 days feeding, however, the pattern has changed considerably 
(TABLE II). The lipase activity of the olive oil fed group is 
lowered, due mainly to a lowering in the heparin-releasable lipase 
activity. The lipase of the rapeseed oil fed rats, however, is 
further elevated, as a result of an increase of the non-releasable 
or residual activity. 
DISCUSSION 
From the data shown it can be seen that the lipase activities 
of rat heart are greatly influenced by fat feeding. Both the heparin-
releasable and the non-releasable lipase activities are significantly 
3 
enhanced, irrespective of the nature of the fat consumed~ The 
enhanced activity of the heparin-releasable part of the lipase will 
lead to an increased uptake of serumtriglycerides in the rat 
hearts 6 . Gumpen and Norum5 calculated that an increased flow of 
only 3% of the daily fat intake to the hearts can account for the 
triglyceride accumulation in the rapeseed oil fed rats. Our 
results show that this increased flow may be caused by the elevated 
lipoprotein lipase activity of the rat hearts. In the olive oil fed 
rats the lipoprotein lipase activity of the hearts is equally en-
hanced by the diet. Oleic acid (the major component of olive oil) 
is however rapidly metabolized, in contrast to erucic acid (comp-
ponent of rapeseed oil). 
When the rats are maintained on the olive oil diet for a 
longer period (10 days), the heparin-releasable lipase activity is 
lowered to an almost normal level (TABLE II). However, in the rape-
seed oil fed animals this activity remains elevated, allowing a 
continuous flo.,., of triglycerides to the hearts. 
From TABLE II it can be seen that, contrary to the olive oil 
feeding experiments, the non-releasable lipase activity in the rape-
seed oil fed rats is further elevated after 10 days feeding. The 
role of this lipase activity is not very well understood. It is not 
clear whether it is operative in vivo inside the heart cells or not. 
That an active lipase in the cardiocytes is present was shown by 
Olson and Hoeschen10 , since triglycerides were shown to serve as an 
energy source during substrate-free perfusion. It was found also 
(E.A.M. de Deckere, Unilever Research, unpublished) that hearts of 
rapeseed oil fed rats continue to beat much longer during substrate-
free perfusion than hearts of control rats. The removal of the tri-
glycerides from the hearts could be explained by increased lipolysis 
of the endogenous triglycerides, which is in accordance with the 
observation that the FFA content of hearts from rats fed rapeseed 
oil, remains elevated2 . Perhaps then a flux of FFA from the hearts 
to the blood would exist, aiding the removal of fat. Part of the 
FFA might then be directed towards the liver, in which Gumpen and 
Norum5 were able to demonstrate increased levels of erucyl-carnitine. 
That liver metabolism is indeed affected by prolonged rapeseed oil 
4 
feeding is also suggested by our finding 11 of increased liver lipase 
activity. 
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SUMMARY 
A diet of 50 cal% rapeseed oil with a high content of erucic acid (C 22:1 n·9) 
given to rats increases the postheparin lipoprotein lipase activity of the plasma by about 
45% after a feeding period of three to six days. 
Dietary erucic acid (C 22:1 n·9) causes fat infiltration and accumulation in the 
rat heart, especially in short· term feeding experiments1 •2 ,. the amount of accumulated 
fat being highest after 3 to 4 days3 • The increase of the total fat content is mainly due 
to an increase of triglycerides containing large amounts of C 22: I. After the sixth day 
the triglyceride content decreases rapidly. 
Some authors showed that different tissues, such as heart4 , liver, kidney and 
adipose tissue'·', contain an enzyme which appears to be identical with the lipoprotein 
lipase in plasma. This enzyme is released into the blood after intravenous heparin in· 
jection, thus increasing the postheparin lipoprotein lipase activity. If this lipoprotein 
lipase is not only localized in the capillary endothelium but also in the tissue cells, this 
enzyme could play a role not only in the removal of intravascular triglycerides but 
also in the disappearance of tissue triglycerides. Therefore we started to study the 
postheparin lipoprotein lipase activity in the plasma of rats fed either rapeseed oil with a 
high C 22: I content, sunflower seed oil or olive oil. 
* Medical School, Rotterdam, The Netherlands. 
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In our first series of experiments (Table I) groups of two male Wistar rats, 8 weeks 
old, were given 50 cal% rapeseed oil (4&% C 22: I), 50 cal% sunflower seed oil or 50 cal% 
olive oil for 6 or II days. In a second type of experiment (Fig. I), groups of two male 
Wistar rats, also 8 weeks old, were given 50 cal% rapeseed oil (48% C 22: I) for I, 2, 3, 6, 
10 and 14 days. 
" t / ~ AO:V• 
c 
m 
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~-·--· 
" £ day rapeseed oil 
Fig.l. Postheparin lipoprotein lipase activity of plasma from rats fed 50 cal% rapeseed oil for 1, 2, 3, 6, 
10 and 14 days. Heparinization time 15 min. Postheparin lipoprotein lipase activity was measured at pH 7.4, 
temperature 25°C, 
Afte< overnight fasting, the rats, weighing 250-300 g, were anaesthetized with 
Nembutal. Heparin (0.1 mg or lO I.U. per 100 g body weight) was administered intra· 
venously. The rats were killed by exsanguination from the aorta. Blood samples were 
collected at 6 or 15 min after the heparin injection. Postheparin lipoprotein lipase activity 
of the plasma was determined, as described by Jansen and Hillsmann 7 . 
I\ IS shown in Table I that a rapeseed oil diet with a high C 22: I (n-9) content in· 
creases the postheparin lipoprotein lipase activity in rat plasma by about 45%. This seems 
to be independent of the various pH values and temperatures during the incubations in the 
various experiments. 
The time dependence of the postheparin lipoprotein lipase activity increase on 
rapeseed oil feeding is presented in Fig.l. The enzyme acitivities are lower than those 
in the previous experiments due to lower pH and temperature. The postheparin lipoprotein 
lipase activity in rat plasma increases obviously between 3 and 6 days of rapeseed oil feeding. 
This rise in postheparin liPoprotein lipase activity coincides with the rapid decrease in tri· 
glyceride cOntent, which suggests a causative correlation with the removal of accumulated 
triglycerides from the heart. 
We thank Mrs A. van Zuylen-van Wiggen and Mrs R. Kurpershoek·Davidov for 
their leciuiical assistance. One of us (HJ .) is indebted to the Nether lands Organization 
for the Advancement of Pure Scientific Research (Z.W.O.) for financial support. 
TABLE I 
POSTHEPARIN LIPOPROTEIN LIPASE ACTIVITY IN RAT PLASMA, AFTER FEEDING 50 CAL% 
RAPESEED OIL, SUNFLOWER SEED OIL OR OLIVE OIL FOR 6 AND 11 DAYS 
Postheparin lipoprotein lipase activity (munits/ml) was determined as the rate of hydrolysis of palmitoyl-
CoA as described by Jansen and HU1smann7 • Differences in pH and temperature of the incubations affect 
the activity of the enzyme, whereas the heparinization time affects the amount of enzyme. 
Heparinization pH 
time (min) 
Temperature Feeding 
period 
(days) 
Diet Ratio Rapeseed oil/ 
r c) 
25 
6 8.5 
29 
8.5 29 
15 
7.5 32 
II 
6 
6 
II 
Rapeseed 
oil 
III.6 
(±3.6) 
179.3 
(±10.1) 
I53.0 
(±21.50) 
100.5 
(±4.2) 
Sunflower Olive 
seed or oil 
oil 
Sunflower Olive oil 
seed oil 
71.0 1.57 
(±4.8) 
136.7 1.31 
(±10.2) 
I02.3 !.50 
(±9.9) 
70.6 1.42 
(±4.7) 
"' !;': 
~ 
~ 
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